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Joint modeling is a collection of statistical methods to properly handle a longitudinal response while
investigating its effects on time to the occurrence of an event. Joint modeling also allows an investigation
of the effects of baseline covariates on both the longitudinal response and the event process. In practice,
the inspiration of biostatistical research arises from clinical and biomedical studies. The data collected from
these studies have always been getting attention due to their particular features that need special consider-
ation when doing an analysis. New statistical methods have developed over time to handle an analysis of
such data coming from these sources. A typical clinical study often involves collecting repeated measure-
ments on a biomarker (e.g., lvmi measurements) along with an observation of the time to the occurrence of
an event (e.g., death), resulting in a joint modeling setup, a model becomes increasingly popular in clini-
cal studies. Joint models can be formulated with a probability distribution (parametric models) or without
assuming a probability distribution (Cox model or semi-parametric Cox PH model) for time-to-event process.
In general, parametric models are pivotal in the joint modeling of longitudinal and time-to-event data.
A non-parametric or semi-parametric model usually leads to an underestimation of standard errors of the
parameter estimates in the joint analysis. However, selection for the joint model framework is quite limited
in the literature. The best choice for the selection of longitudinal model can be made based on the observed
longitudinal data, and the best survival model can be selected based on the survival data, using standard
model selection procedures for these models.
In this thesis, we develop and implement a Bayesian joint model framework, consisting of longitudi-
nal process involving continuous longitudinal outcome and two parametric accelerated failure time (AFT)
models (Log-logistic (model 1) and Weibull (model 2)) for survival process. We introduce a link between
the parametric AFT survival processes and the longitudinal process via one parameter of association (φ)
corresponding to shared random effects. A linear mixed-effect model approach is used for the analysis of
longitudinal process with the normality assumption of longitudinal response along with normal and inde-
pendent distribution assumption for both random effects and the error term of the longitudinal process.
Finally, Bayesian approach using the Markov chain Monte Carlo method with the Gibbs Sampler technique
is adopted for the statistical inference.
The motivating ideas behind our work on Bayesian joint models using parametric AFT event processes
are: (a) although there are well-known techniques to test the proportionality assumption for the Cox PH
model, checking this assumption for joint modeling has received less attention in the literature. To our
knowledge, no statistical package is available to check the PH assumption under the joint modeling setup.
AFT models are particularly useful when the PH assumption is in question, (b) there are two integrals
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involved in the specification of joint models: (1) a unidimensional integral with respect to time which is
relatively straightforward to approximate using numerical techniques, and (2) a multidimensional integral
with respect to random effects which is the main computational burden to fit a joint model. It is relatively
straightforward to handle (2) under the Bayesian framework, implemented using Markov Chain Monte Carlo
(MCMC) techniques, (c) Bayesian approach does not depend on asymptotic approximation for statistical
inference and (d) availability of software makes Bayesian implementation for complicated models relatively
more straightforward and simple than frequentist methods.
We also develop computational algorithms to fit the proposed Bayesian joint model approach and imple-
mented it in WinBUGS (a Bayesian software) and R software. Analysis are performed with an application
to aortic heart valve replacement surgery data (available in joineR package in R software) to illustrate the
performance of our two proposed models with the aim of comparing the efficiency of two types of valves
based on tissue type (Stentless porcine tissue or Homograft) implanted during surgery and the association
between internal covariate (longitudinal response: log.lvmi) and the occurrence of an event (death) after the
surgery. Model selection is performed using the deviance information criterion (DIC).
Study analysis results for both joint models indicate the statistically significant and strong association
between internal covariate (longitudinal response: log.lvmi) and the relative risk of death after aortic valve
replacement surgery. Results show that one gm/m2 increase in the value of log.lvmi after the surgery reduces
the relative risk of death by about 62 % (model 1) and 60 % (model 2), respectively, after controlling for
other factors. Moreover, age of the patient (age) and preoperative left ventricular ejection fraction (lv) are
found statistically significant for the risk of death after surgery. However, we found no significant difference
between the efficiency of two types of valves implanted during surgery based on tissue type (Stentless porcine
tissue or Homograft) associated with reducing the risk of death in the patients after surgery. Finally, based
on DIC, we recommend, Bayesian joint AFT model with Weibull distribution fits the motivated data set
more efficiently than Bayesian joint AFT model with Log-Logistic distribution.
Developing joint models using AFT event processes, writing the model in a hierarchical framework for
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1 Introduction
In many areas of study including biological, environmental, medical and health applications, a common
problem is to investigate the effects of a longitudinal response on time to the occurrence of an event. That
is, the longitudinal response is considered to be a time-dependent covariate of the event process. Since
data are collected only intermittently in a follow-up study, missing observations and measurement errors are
commonly seen in longitudinal data ( Rizopoulos 2012). Therefore, analysis of longitudinal data requires
special attention to take into account measurement error and missing data. The problem becomes even more
challenging when the objective is to model an event process along with a longitudinal response in order to
explore the effects of the longitudinal response on time to the occurrence of the event. For example, CD4
cell levels may be recorded longitudinally along with an observation of the onset of AIDS (Abrams et al.
1994), and we might be interested to investigate the effects of CD4 cell counts on time to the onset of AIDS.
The modern approach to handle an analysis when both longitudinal and survival responses are collected
is to jointly model the longitudinal response and the time-to-event outcome through shared random effects
(Faucett and Thomas 1996, Wulfsohn and Tsiatis 1997, Hogan and Liaired 1997, Henderson et al. 2000,
and Yu et al. 2004). Joint modeling of longitudinal and time-to-event processes is the central theme of this
thesis.
To summarize, joint modeling is a collection of statistical methods to analyze longitudinal and survival data
simultaneously when (Murawska 2014)
1. there is an event process, where the event time distribution depends on a longitudinally measured
internal covariate or longitudinal response;
2. the longitudinal data are subject to measurement error and missing observations; and
3. the objective is to understand the effect of the longitudinal response on time to the occurrence of the
event.
In general, joint modeling is a collection of statistical methods to properly handle a longitudinal response
while investigating its effects on time to the occurrence of an event. (Wulfsohn and Tsiatis 1997, Tsiatis
et al. 1995). Joint modeling also allows an investigation of the effects of baseline covariates on both the
longitudinal response and the event process. An excellent review of the joint modeling approach is given in
Tsiatis and Davidian (2004).
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Two general classes of models are in common use for regression analysis of time-to-event data: accelerated
failure time (AFT) models where the covariates act multiplicatively on time (i.e., the effect of covariates is
to decelerate or accelerate the time to the occurrence of the event), and proportional hazards (PH) models
where the covariates act multiplicatively on the hazard function (Cox 1972). Parametric PH models are
commonly considered to describe the time-to-event process of joint modeling. Note that the use of the semi-
parametric Cox PH model (Cox 1972) in joint analysis leads to an underestimation of the standard errors
of the parameter estimates (Hsieh et al. 2006, Rizopoulos 2012), and therefore most methods used for joint
modeling are based on parametric response distributions (Hwang and Pennell 2014). The key assumption
in the PH model is the proportionality assumption concerning the effects of covariates. Although there are
well-known techniques to test the proportionality assumption for the Cox PH model (Kleinbaum and Klein
2012), checking this assumption for joint modeling has received less attention in the literature.
An alternative framework involves considering AFT models, which is particularly useful when the pro-
portionality assumption fails. For joint modeling, Tseng et al. (2005) described the maximum likelihood
approach under the AFT assumption, and highlighted some challenges of modeling the baseline hazard func-
tion in a likelihood setting. To circumvent this problem, they only considered a piecewise constant baseline
hazard function. As far as computational resources are concerned, the JM package (Rizopoulos 2010) of
the statistical software R (R Core Team 2018) has been developed to fit joint models based on the PH
assumption of the event process. In this thesis, we propose joint model methodology for AFT models, and
develop a Bayesian framework for statistical inference.
1.1 Motivating Example: Aortic Valve Replacement and Heart
Functioning
Prevalence of heart diseases is increasing worldwide and is the leading cause of death. In 2015, the deaths
caused by heart diseases were 45 % of all non-transmissible disease deaths, suggesting approximately 8.9
million people died from heart diseases worldwide (Wang et al. 2016). Heart disease is the second leading
cause of death. In Canada after cancer, heart diseases accounted for almost 20 % of all other causes of deaths
(Lix et al. 2018).
Heart valve disease is a common heart condition which occurs if one or more of the heart valves do not
work well. Globally, the burden of heart valve disease is increasing. The main reason for this increase in
heart valve disease is linked with the ageing of the world population and the failure to eradicate rheumatic
heart disease in the developing world (Carapetis et al. 2005). The burden of heart valve disease increased
by 13 % in the population with age ≥ 75 years old (Nkomo et al. 2006). Untreated valve disease leads to
premature death, whereas valve surgery may prolong life (Nishimura et al. 2014).
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Tricuspid, pulmonary, mitral, and aortic valves are the four types of valves of the heart. Each valve
has tissue flaps, and with the heartbeat, these tissue flaps open and close. The function of flaps is to make
sure blood flows in the right direction through the four chambers and moves to the rest of the body, and
these flaps are called valve leaflets (https : //my.clevelandclinic.org/health/articles/17067−heart−valves).
The aortic valve is a one-way valve, and the function of the aortic valve is to prevent the flow of
blood back into the heart. When the aortic valve narrows, valve leaflets lose controlling its ability to
open normally; pumping blood into the aorta becomes harder. Aorta is the largest and main artery in
the body. The aorta transmits blood away from the heart to the rest of the body. Stiffening of the valve
leaflets causes aortic stenosis. Aortic stenosis usually develops among individuals aged ≥ 65 years old,
but can also develop in younger people born with an abnormal valve or develop rheumatic heart disease
(https : //www.nhlbi.nih.gov/health− topics/heart− valve− disease).
Currently, there are no medicines, which can cure heart valve disease. However, medicines and change
in lifestyle can treat symptoms and delay problems for many years. Ultimately, surgery is done to repair
or replace a damaged heart valve. If the heart valve cannot be repaired, the faulty valve is removed and
replaced during surgery (https : //www.nhlbi.nih.gov/health− topics/heart− valve− disease). The most
common heart valve surgery performed is the aortic valve replacement (AVR) surgery (Bridgewater et al.
2011). In western countries, the most common form of valvular heart disease is the aortic stenosis, and the
standard treatment is aortic valve replacement (AVR). Annually in the United States alone, up to 85,000
AVR surgeries are performed (Nishimura et al. 2014).
Usually, two types of valves are used for aortic valve replacement (AVR) surgery: biological and me-
chanical. Mechanical valves come in three main types caged ball, tilting-disc and bileaflet with various
modifications on these designs (Gott and Alejo et al. 2003). Now a days caged ball valves are no longer
implanted, but many patients are still living with this type of valve (Pibarot and Dumesnil 2009). Bileaflet
valves are the most frequently implanted mechanical valves in the patients today (Bloomfield 2002). On the
other hand, biological valves are made from pig, cow, or human heart tissues. Biological valves can be of nu-
merous types such as bovine, pericardial or porcine valves, stented or stentless, homografts, and pulmonary
autografts (Chan et al. 2011). Most biological valves are attached on a stent for ease of implantation.
However, stentless valves may have superior hemodynamic with lower gradients and larger effective opening
areas. Conflicting evidence exists in the literature and it is uncertain about the preference of stentless valves
over stented valves (Gulbins and Reichenspurner 2009).
Another type of biological valve is homograft valve, made from tissues of a human donor. The age of
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a patient is of significant attention in the choice of the type of valve: older patients generally being offered
biological valves and younger patients being offered mechanical valves. More specifically, biological valves
are commonly used when the age of the patient is between 60 and 65 years. Biological valves may also be
offered to younger patients who have multiple co-morbidities and if the life expectancy is lower than the
assumed durability of the biological valve (Vahanian et al. 2007).
Nowadays, homografts valves are not used frequently. There is conflicting evidence in the literature
about its functionality. A recent study (El-Hamamsy et al. 2010) reported a significantly higher rate of
valve dysfunction at eight years in homografts compared to stentless valves (63 % versus 15 %, p < 0.001),
and also indicate the higher rate of re-operation (10 % versus 0 % , p = 0.024). Evidence from another study
suggested 16 % and 12 % mortality with stentless and homograft valves, respectively (Henryk et al. 2003).
Lim et al. (2008) described a longitudinal study on detecting effects of different heart valves, differing
on type of tissue, implanted in the aortic position. The data consisted of longitudinal measurements on
left ventricular mass index (lvmi) for each patient after surgery. The patients were followed prospectively
after surgery and time to death was recorded, resulting in survival analysis data. Several baseline covariates
were also recorded, including age, sex, preoperative left ventricular ejection fraction and implanted aortic
prosthesis (homograft or stentless porcine tissue). Here we are interested in the association between lvmi
and the risk for death. In addition, the effects of the baseline covariates on the survival outcome as well
as on lvmi are also of interest. This is a setup of the joint modeling problem, with death is the event of
interest and lvmi is the longitudinal response (time-dependent covariate for the event process). The dataset
is publicly available in the joineR package (Philipson et al. 2018) of R.
1.2 Statistical Background
The inspiration of biostatistical research arises from clinical and biomedical studies. The data collected from
these studies have always been getting attention due to their particular features that need special considera-
tion when doing an analysis. New statistical methods have developed over time to handle an analysis of such
data coming from these sources. A typical clinical study often involves collecting repeated measurements on
a biomarker (e.g., lvmi measurements) along with an observation of the time to the occurrence of an event
(e.g., death), resulting in a joint modeling setup.
Follow-up studies are common in clinical trails, where measurements are taken repeatedly on the same
subject (e.g., human , animal, electronic component) at different points over time. Data resulting from
such follow-up studies are called longitudinal data. Analysis of longitudinal data is an active research area,
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particularly due to various details not part of standard data analysis, including participant dropout from lon-
gitudinal studies and inherent correlation between repeated measures from the same participant (Rizopoulos
2012). Longitudinal measurements can be either continuous or discrete (Salkind and Rasmussen 2008). In
this thesis, the focus is on continuous repeated measurements. Many well-established methods are available
in statistical literature to analyze the longitudinal data. For example, linear mixed-effects (LME) models
(Laird and Ware 1982) and marginal and transitional models (Liang and Zeger 1986) are highly efficient in
describing data with ranging characteristics.
Another common feature of a follow-up study involves understanding the distribution of time to the oc-
currence of an event. Data collected on times to the occurrence of an event are commonly known as survival
or time-to-event data (Lawless 2011). Over the last few decades, survival analysis continues to be an active
research area in statistical field. A typical survival analysis involves regression methodology, exploring the
effects of certain covariates on times to the occurrence of the event (Collett 2015). The event of interest
could be death, disease, start time of smoking etc. Analysis of time-to-event data also provides valuable
information on, e.g., the effectiveness of a treatment for a specific type of disease and the covariates that are
significantly associated with the recovery of a patient.
Time-to-event data have two key characteristics: censoring and truncation. These two characteristics
make survival analysis different from standard statistical analysis. In practice survival data may contain
either complete or incomplete information on times to the occurrence of the event. If the exact time to
the occurrence of the event is observed over the follow-up period, then we have complete information. On
the other hand, if only partial information is available in that we only know an individual has survived to a
certain time point (exact time to failure is not known), then this leads to incomplete or censored observation.
In this thesis, we only consider right censoring, which occurs when (Kleinbaum and Klein 2012):
1. the event is not experienced by the end of the study,
2. lost to follow-up during the study, and
3. withdraw from the study.
Moreover, there are two types of censoring mechanism: informative and non-informative censoring (Rizopou-
los 2012). Informative censoring occurs when the probability of censoring is related to the expected failure
time, whereas non-informative censoring occurs when the probability of censoring depends on covariates (e.g.
gender, age, etc.) unrelated to the event process (Rizopoulos 2012).
Another common feature of time-to-event data is truncation. Truncation occurs when there is a late
entry of a participant into the study (Lee and Wang 2003). Due to censoring and truncation, standard
statistical methods cannot handle an analysis of survival data. There are many well-established parametric
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and non-parametric methods available for survival analysis. Among all these, the most widely used method
in epidemiological and medical studies is the Cox proportional hazards (PH) model (Cox 1972).
When dealing, longitudinal and time-to-event data simultaneously, statistical analysis becomes compli-
cated due to the presence of missing data and within-individual correlations in the longitudinal response,
and building a model to explore the association between the longitudinal response and the event process.
To address these issues, joint analysis of survival with repeated measures is growing rapidly in recent years
(Faucett and Thomas 1996, Wulfsohn and Tsiatis 1997, Hogan and Liaired 1997, Henderson et al. 2000, and
Yu et al. 2004), and many methods have been proposed for valid and efficient statistical inference (Hatfield
et al. 2012).
To analyze longitudinal and time-to-event data separately and in joint modeling framework, standard
methods and computer packages are available in the literature (Guo and Carlin, 2004). Early work on joint
modeling includes Wulfsohn and Tsiatis (1997), Henderson et al. (2000), Wang and Taylor (2001), and Tsi-
atis and Davidian (2004). More recent work includes Ye et al. (2008), Rizopoulos (2009), Wu et al. (2010),
Alber and Shih (2010), Huang et al. (2011), and Hatfield et al. (2012). Chapter 2 reviews the fundamental
framework of joint models.
Some authors proposed extensions of the classical joint modeling framework. A joint model developed by
Chi and Ibrahim (2006) considered multivariate longitudinal and survival data. Liu and Huang (2009) and
Kim et al. (2012) discussed methods to simultaneously take into account longitudinal and recurrent event
data, times of event (death) and time of recurrent events simultaneously. Elashoff et al. (2008) and Rizopou-
los (2012) proposed joint models for competing risk problems. Dantan et al. (2011) proposed joint models
to explore association between an illness-death model and longitudinal response. He and Luo (2013) consid-
ered the longitudinal data with multiple outcomes of different types and outcome-dependent terminal events.
Fitting a joint model is a computationally intensive task as it requires to approximate multiple integrals
that do not have an analytic solution except in very special cases. Currently there are several software
implementations available to fit joint models. For example, the JM package (Rizopoulos 2010) in R fits
joint models for a continuous longitudinal outcome and an event time process using the maximum likelihood
method, whereas the joineR package (Philipson et al. 2012) fits joint models following the formulation of
Henderson et al. (2000).
Most of the joint models and software packages have been developed based on parametric and semi-
parametric PH models (Guo and Carlin 2004, Terrera et al. 2011, and Wulfsohn and Tsiatis 1997). However,
if there is a violation of PH assumption, the attractive alternative model choice is the parametric accelerated
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failure time (AFT) models (Tseng et al. 2005). In this thesis, we consider the Weibull and log-logistic AFT
models, and develop Bayesian methods for statistical analysis and computation.
To summarize, this work on Bayesian joint models using parametric AFT event processes is motivated
by the following facts.
1. Although there are well-known techniques to test the proportionality assumption for the Cox PH
model, checking this assumption for joint modeling has received less attention in the literature. To our
knowledge, no statistical package is available to check the PH assumption under the joint modeling
setup. AFT models are particularly useful when the PH assumption is in question.
2. There are two integrals involved in the specification of joint models: (a) a unidimensional integral
with respect to time which is relatively straightforward to approximate using numerical techniques,
and (b) a multidimensional integral with respect to random effects which is the main computational
burden to fit a joint model. It is relatively straightforward to handle (b) under the Bayesian framework,
implemented using Markov Chain Monte Carlo (MCMC) techniques.
3. Bayesian approach does not depend on asymptotic approximation for statistical inference.
4. Availability of software makes Bayesian implementation for complicated models relatively more straight-
forward and simple than frequentist methods.
1.3 Objectives of the Thesis
The background and objectives of this study are described in various places in the above sections. Here we
summarize our objectives below.
1. Developing joint models using AFT event processes.
2. Writing the model in a hierarchical framework for Bayesian implementation.
3. Developing computational algorithms to fit joint models, implemented in WinBUGS (a Bayesian soft-
ware) and R.
4. Analyzing the aortic valve data using our approach.
1.4 Organization of the Thesis
Chapter 2 reviews the fundamental statistical models and methods for longitudinal and survival data, leading
to the the joint model framework. Basic concept of Bayesian inference and MCMC are also presented in
chapter 2. In chapter 3, we present the formulation of the proposed joint models in a Bayesian framework.
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There, we also discuss computational algorithms and software implementation. The analysis of aortic valve
data is presented in chapter 4. In chapter 5, we summarize our findings, highlighting some limitations of our
work and presenting scope for future research.
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2 Joint model: General Overview
Joint models consist of two basic sub-models: longitudinal and time to event sub-models. In this chapter,
we will discuss the fundamental concepts and standard formulation of the joint model and Bayesian inference,
which leads to the foundation of this thesis. We start with the basic concepts and methods of longitudinal
data analysis for a continuous response variable (section 2.1). Then, we review the essential elements of
time-to-event (section 2.2) data analysis, discuss non-parametric methods (section 2.2.1), parametric meth-
ods (section 2.2.2) and PH and AFT regression models in section 2.2.3. Finally, we review existing standard
joint longitudinal-survival model, methods, and estimation processes (section 2.3), and also discuss Bayesian
Inference (section 2.4), and Markov chain Monte Carlo (MCMC) (section 2.5).
2.1 Longitudinal Sub-model
Longitudinal data consist of the measurements on response variable taken from same individual over sev-
eral observation times and these measurements can be continuous or discrete (e.g., binary) (Salkind and
Rasmussen 2008). In this thesis, we only consider continuous outcome variable. Longitudinal data can
be balanced or unbalanced. For balanced data, all individuals are measured at a common set of occa-
sions, whereas for unbalance data, numbers of measurements and measurement times vary across individuals
(Colosimo et al. 2012 and Fitzmaurice et al. 2008). Our proposed joint modeling framework can handle
both balanced and unbalanced longitudinal data.
Longitudinal data analysis involves various details not part of standard data analysis, including partic-
ipant dropout from longitudinal studies and the inherent correlation (Wu 2009 and Viviani 2012) between
repeated measures from the same participant (commonly known as a within-subject variation). In this thesis,
we consider only linear models to describe a longitudinal process. The following section gives an overview
of the linear mixed-effects model (LME) for longitudinal data.
2.1.1 Linear Mixed-Effects Model
In statistical literature, many well-established methods are available for longitudinal data analysis, including
linear mixed-effects (LME) models (Laird and Ware 1982) and marginal and transitional models based on
generalized estimating equations (GEE) approach (Liang and Zeger 1986). A linear mixed-effects model is
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different from a standard regression model in that it takes into account within-subject correlation, between-
subject correlation, random effects and provides a valid statistical inference for longitudinal data. Linear
mixed-effects models can describe longitudinal data with ranging characteristics. For example, LME models
allows characterization and comparison of changes in the response of interest over time, accommodation of
incomplete data, handle both balanced and unbalanced data and model the covariance in a parsimonious
way (Fitzmaurice et al. 2008). The formulation of the model is simple, and the application of the maximum
likelihood method for statistical inference is straightforward.
Let n randomly selected and independent subjects participated in the study, and mi denote the number
of observations for individual i, i = 1, 2, . . . , n. Let yi be the mi× 1 vector of responses for individual i. The
linear mixed-effects model can be written as (Laird and Ware 1982)
yi = xiα + zibi + εi, (2.1)
where xi and zi are known design matrices, α is a vector of fixed-effects parameters, bi is a vector of
random effects, and εi is a vector of measurement errors. We assume that bi ∼ N(0,Σ) (Verbeke 1997),
εi ∼ N(0, σ2Ii) (McCrink et al. 2013), and bi and εi are independent, where Σ is the covariance matrix for
bi (Verbeke 1997), σ
2 is the variance for each of the components of εi, and Ii is an identity matrix of order




where yi|bi ∼ N(xiα + zibi, σ2Ii) and f(bi) is the density functions of bi. Estimation of the parameters
can be obtained using the expectation-maximization (EM) algorithm (Dempster and Laird 1977, Laird and
Ware 1982) or Newton-Raphson method (Jennrich and Schluchter, 1986).
2.2 Survival Analysis
In this section, we discuss the basic concepts of survival analysis.
Important Quantities of Survival Analysis
Let T be a non-negative random variable representing survival times. Lifetimes distributions can be charac-
terized by any of the following five quantities (for details, see Lawless 2011).
1. Cumulative Distribution Function (CDF)
The cumulative distribution function is the probability that the event will occur before time t.
F (t) = Pr(T ≤ t). (2.3)
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F(t) can take the value from 0 to 1 and is a monotone increasing function of t.
2. Survival Function
Survival function, denoted by S(t), is the probability that a subject survives longer than time t. The survival
function can be written as
S(t) = Pr(T > t). (2.4)
S(t) is a monotone decreasing function, with S(0) = 1 and S(∞) = 0. Note that
S(t) = 1− F (t). (2.5)
3. Probability Density Function (pdf)







4. Hazard rate or Hazard Function
Hazard rate, denoted by h(t), is the chance that a subject who has survived up to time t experiences the
event of interest at the next instant in time. In other words, hazard function is the instantaneous probability
of an event to occur within a small time change t+ ∆t given that event has not occurred until time t:
h(t) = lim
∆t→0
Pr[t ≤ T ≤ t+ ∆t|T ≥ t]
∆t
. (2.7)





5. Cumulative Hazard Function






The functions f(t), S(t) and h(t) are mathematically equivalent specifications of the distribution of T . It is
easy to see that (Lawless, 2011)
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H(t) = −logS(t). (2.13)
2.2.1 Non-Parametric Methods of Survival Analysis
In this section, we present two non-parametric methods to estimate survival function and cumulative hazard
function.
Kaplan-Meier Estimate of Survival Function
Kaplan and Meier (1958) proposed a non-parametric method to estimate survival probabilities. Let there be
p distinct ordered lifetimes t(1) < t(2) < . . . < t(p). Also, let nti be the number of individuals at risk at time
t(i), and let dti be the number of individuals died at t(i). The Kaplan-Meier (KM) estimate of the survival








, t ≥ 0. (2.14)
Nelson-Aalen Estimate Cumulative Hazard Function






, t ≥ 0 (2.15)
Note that cumulative hazard plots are the diagnostic tool and are used to check the assumption of a para-
metric model. For further details about the estimation of H(t) and cumulative hazard plots, see Nelson
(1972) and Aalen (1978).
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2.2.2 Parametric Distributions for Survival Analysis
For a positive-valued random variable T , Table 2.1 displays the probability density functions and survival
functions for some of the widely used distributions in survival analysis (Lawless 2011). See Appendix A
for details about the characteristics of these distributions. As we will see in the subsequent sections, these
distributions play a very important role in formulating regression models for survival data analysis.
Table 2.1: Most widely used Parametric distributions for survival analysis
Distribution Parameters Probability Density Survival Function
Function: f(t) S(t)
Exponential ρ > 0 ρ exp(−ρt) exp(−ρt)
Weibull ρ, κ > 0 κ ρ (ρt)(κ−1) exp [−(ρt)κ] exp [−(ρt)κ]
Log-Logistic ρ, κ > 0 κ ρ (ρt)(κ−1)[1 + (ρt)κ]−2 [1 + (ρt)κ]−1
Logistic µεR, σ > 0 σ−1 exp [(t− µ)σ−1] [1 + exp( (t− µ)σ−1)]−1
[1 + exp( (t− µ)σ−1)]−2





Gamma ρ, κ > 0 [ρκtκ−1 exp(−ρt)][Γ(κ)]−1 1− Ik(ρt)
Gompertz a > 0 t exp[ta+ ta−1(1− exp(ta))] exp[ta−1(1− exp(ta))]
2.2.3 Regression Models For Survival Analysis
Regression models are used to quantify the effects of covariates (time-independent or time-dependent) on the
response variable. In the analysis of survival data, accelerated failure time (AFT) and proportional hazards
(PH) are the two most popular families for regression analysis ( Lawless 2011). The Cox proportional hazards
model (Cox 1972) is a semi-parametric PH model and is appealing due to its robustness property against
the distributional assumption and relative risk interpretation of the parameters. An alternative modeling
framework when the PH assumption fails is the AFT family (Collett 2015). In the following sections, we
briefly present the formulations of these two families for regression analysis (for more details, see Lawless
2011).
Proportional Hazards (PH) Model
The key feature of the PH model is the proportionality assumption. According to proportional hazards
assumption: the effect of the covariate is to increase or decrease the hazard by a proportionate amount
which does not depend on t ((Lawless 2011). In other words, a covariate has multiplicative effects on the
hazard in a PH model. The PH model can be conveniently expressed using the hazard function as follows
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(Cox 1972):
h(t|x) = h0(t) exp[x′β]. (2.16)
where h0(t) is the baseline hazard function , x is a vector of covariates, and β is the corresponding vec-
tor of regression coefficients. h0(t) may have a specified parametric form or it may be left as an arbitrary
nonnegative function. The semi-parametric Cox PH model assumes an arbitrary (unspecified) nonnegative
function for h0(t), whereas parametric PH models ((Lawless 2011) assume a parametric form for h0(t) such
as Weibull or exponential.
Note that the assumption of PH is strong and it is important that it be checked. The AFT family is an
attractive alternative to the PH models when this assumption fails (Wei, 1992).
Accelerated Failure Time Model
Accelerated failure time (AFT) models can be used to predict times to failure. Proportional hazards models
the effect of predictors on the hazard function, whereas the AFT models assume a direct relationship be-
tween survival times and covariates (George 2014). To clarify, consider a predictor signifying the presence
or absence of a disease. The AFT model assumes that the disease either accelerates or decelerates the rate
of survival of a patient. In other words, if S1(t) and S2(t) denote the survival functions for the presence and
absence of the disease, respectively, then the AFT model assumes the relationship S1(t) = S2(ηt), where η
is the acceleration factor. If η > 1, then a diseased individual has longer median survival time compared
to a non-diseased individual, whereas if η < 1, then a diseased individual has shorter median survival time
compared to a non-diseased individual (Collett 2015).
The AFT model can be expressed in terms of log survival time as (George 2014)
log T = −x′β + ε. (2.17)
If T has a Weibull, log-logistic or log-normal distribution, then log T can be expressed in the form equation
(2.17), with ε having a standard extreme value distribution, a standard logistic distribution and a standard
normal distribution, respectively. Thus, Weibull, log-logistic and log-normal distributions belong to the AFT
family.
For time-independent covariates, the probability distribution function, survival function, and hazard
function of T can be expressed as (Kalbfleisch and Ross 2002)
f(t|x) = f0(t exp(−x′β)) exp(−x′β), (2.18)
S(t||x) = S0(t exp[x′β]), (2.19)
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h(t|x) = h0(t exp(−x′β)) exp(−x′β), (2.20)
where f0(·), S0(·) and h0(·) are the baseline probability density function, baseline survival function and





which can be considered as a transformed time scale defined by the covariate process. With this trans-
formation, the probability distribution function, survival function, and hazard function for AFT models can
be expressed as (Cox and Oakes, 1984)
f(t|x(t)) = f0(ψ(t)) exp(−x′(t)β), (2.22)
S(t|x(t)) = S0(ψ(t)), (2.23)
h(t|x(t)) = h0(ψ(t)) exp(−x′(t)β). (2.24)
Note that the Weibull and exponential distributions are the only distributions which are closed under both
PH and AFT family. Figure 2.1 shows some widely used regression models for time-to-event data. In this
thesis, we will use Weibull and log-logistic AFT models with time-dependent covariates to formulate joint
models.
Figure 2.1: Commonly used AFT and PH models for survival data analysis.
2.3 Joint Model (JM)
Recall that the objective of joint modeling is to estimate the effect of a longitudinal response on time to
the occurrence of an event. To achieve this goal, the longitudinal response is considered as an internal
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time-dependent covariate for the event process under a regression setting. Note that valid inference requires
a framework in which the underlying relationship between the event process and the longitudinal response
is explicitly acknowledged. Although developing such a framework is conceptually straightforward, the im-
plementation becomes complicated due to the nature of the data observed. Therefore, in order to properly
incorporate the internal covariate into the event process for a valid inference, it is desirable to use a com-
prehensive framework that takes into account measurement errors and missing data (Rizopoulos 2012). In
this section, we present the standard approach of joint modeling, where the longitudinal response is linked
to the time-to-event process through shared random effects (Henderson et al. 2000).
As mentioned above, joint models consist of two sub-models: a model that takes into account the mea-
surement error and missing data in the time-dependent covariate to estimate its true values (longitudinal
model), and another model that uses these estimated values to quantify the association between this covari-
ate and the time to the occurrence of the event (time-to-event model). The motivating idea behind the joint
modeling techniques is to couple the time-to-event model with the longitudinal model (Rizopoulos 2012).
The standard approach is to consider a linear mixed-effects model for the time-dependent covariate (i.e., the
longitudinal response) and a PH model for the association analysis (Guo and Carlin 2004).
The maximum likelihood method is commonly used for statistical inference (McCrink et al. 2013,
Schluchter 1992), implemented via Newton-Raphson method or EM algorithm ((Dempster and Laird 1997).
Let there be n subjects with lifetimes denoted by T1, T2, . . . , Tn. Assuming that the data are subject to
right censoring, we observe ti = min(Ti, Ci), where Ci > 0 corresponds to a potential censoring time for
subject i. Letting δi = I(Ti ≤ Ci) that equals 1 if Ti ≤ Ci and 0 otherwise, the observed data for individual
i consist of {ti, δi}, i = 1, 2, . . . , n, where ti is a lifetime or censoring time according to whether δi = 1 or
0, respectively. Also, assume that the ith subject provides a set of longitudinal quantitative measurements
{yij , j = 1, 2, . . . , ni} at times {sij , j = 1, 2, . . . , ni}. Then the likelihood contribution for individual i can be




p(yij |bi,θ)p(ti, δi|bi,θ)p(bi|θ)dbi, (2.25)
where θ denotes the full parameter vector and bi denotes the vector of shared random effects for individual i.
The main difficulty with the maximum likelihood method is that it requires evaluation of multiple in-
tegrals: a one-dimensional integral with respect to time for p(ti, δi|bi,θ), and a multi-dimensional integral
with respect to the random effects bi. These integrals do not have an analytic solution in general (Rizopoulos
2012). The integral with respect to time can be approximated using the Gauss-Kronrod rule (Press et al.
2007), but the integrals with respect to the random effects are computationally expensive and complicated,
especially when the dimension of the random effect increases (equation 2.25). The numerical approximation
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methods such as Gauss Hermit rule (Wulfsohn and Tsiatis 1997, Henderson et al. 2000, Song et al. 2002 and
Rizopoulos et al.2008), Laplace approximation (Rizopoulos et al. 2009), and Bayesian estimation approach
(Xu and Zeger 2001, Guo and Carlin 2004) are used to solve this issue.
Bayesian approach is also considered to fit joint models (e.g., Faucett and Thomas, 1996; Faucett et
al., 2002; Xu and Zeger, 2001; Brown et al., 2005; Guo and Carlin, 2004). Although expensive in terms of
computational time, Bayesian approach has some advantages as described below.
• The approximation of the integrals with respect to the random effects is straightforward via MCMC.
• As opposed to the maximum likelihood method, asymptotic approximation is not required for statistical
inference.
• With the availability of Bayesian software (e.g., WinBUGS, JAGS), it is relatively easier to implement
MCMC for Bayesian inference.
2.4 Bayesian Inference
In statistical inference, for the interpretations of probability, there are two schools of thought: Bayesian
inference and frequentist inference (Boldgiv 2004). The difference between these two approaches is based on
the nature of probabilities. The most widely used statistical methods are known as frequentist (or classical)
methods. These methods treat the unknown parameters as a fixed constant and describe the probability as
the limit of relative frequencies of an event. On the other hand, in Bayesian methods, the parameters are
treated as random variables (Van et al. 2014).
The term “Bayesian” comes from the well-known Bayes’ theorem, named after the Reverend Thomas
Bayes (Bayes and Price 1763). He was an English statistician and Presbyterian minister in the eighteenth-
century. Bayes was captivated in solving the question, what is the probability of one event? He first used
conditional probability to provide an algorithm that uses evidence to calculate the limits on an unknown
random parameter.
Generally, Bayesian inference is used as a complement to frequentist inference. The line drawn between
the two approaches is ambiguous. The Bayesian approach is different from traditional frequentist approaches.
The actual distinction between Bayesian and frequentist is that how someone explains the probability (Bol-
stad and Curran 2016). In this thesis, we describe the Bayesian concepts based on prior and posterior
distributions, authentically used in applied work.
Bayesian inference is a tremendously powerful tool for modelling the random variable, such as the value
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of a regression parameter, a demographic statistic, or the part of speech of a word. Bayesian approach is
used to handle the following uncertainty situations in the model (Boldgiv 2004)
• Data is limited.
• Model overfitting.
• If the information is not contained in the data, but we want to model the data and we have to believe
that some facts are more likely than others.
Bayesian approach is a useful tool to model the data when the parameters of interest are considered as
random variables (Van et al. 2014). For example, we are interested in estimating the parameter or vector
of parameter θ from the data y with n number of observations and we want to use the statistical model
described by the marginal density p(y|θ) (conditional probability of data y given parameters θ).
The fundamental elements of the Bayesian approach are (Bolstad and Curran 2016):
• Prior distribution; the probability distribution for θ formulated as π (θ). The prior distribution
describes the mean, the spread and the skewness about the parameter before the data is assessed.
• A statistical model p(y|θ) called likelihood and it describes the distribution of observed data y given
θ.
• Update the information by combining the information from the prior distribution and the posterior
distribution (data through the calculation of the p (θ|y) of the parameter or the vector of parameters.
Thus, in the Bayesian paradigm, the main idea is to combine data and prior knowledge on a parameter
(or a vector of parameters) and likelihood (p(y|θ)) to determine its posterior distribution (the conditional
density of the parameter given the data).
2.4.1 Prior Distribution
A prior probability distribution, often known as prior, is the probability distribution of an unknown quantity
that would express one’s beliefs about this quantity before some evidence is taken into account (Gelman et
al. 2013). The uncertain quantity may be a parameter or vector of parameters of the model or a latent
variable rather than an observable variable. Parameters of prior distributions are known as hyperparameters
(Bolstad and Curran 2016). Many methods can be used to create or choose the priors (Carlin and Louis
2008). For example, a prior can be determined from past information, such as previous experiments or a
prior can be predicted from the subjective conclusion/ assessment of an experienced expert. Here we will
discuss some widely used priors.
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Non-informative Priors
Non-informative or uninformative priors are created to reflect a balance among outcomes when no informa-
tion is available. A non-informative prior can also be used if the prior distribution is ”flat” relative to the
likelihood function. These priors have minimal impact on the posterior distribution of θ. For more formal
development of non-informative priors, see Box and Tiao (2011).
Improper Priors
A prior π(θ) is said to be improper if ∫
π(θ)dθ =∞.
For example, a uniform prior distribution defined on real line as π(θ) ∝ 1 for −∞ < θ <∞ is an improper
prior. Improper priors usually generate non-informative priors and proper posterior distributions and are
frequently used in Bayesian inference.
Informative Priors
A prior distribution, which is not dominated by the likelihood, is called an informative prior and has an
impact on the posterior distribution.
Conjugate Priors
If the prior distribution and posterior distributions belong to the same family of distributions, then this
kind of prior is called a conjugate prior. In this case, both posterior and the prior distribution has the same
distributional form. A desire for computational convenience partially drove the development of conjugate
priors and the conjugacy provides a practical way to obtain posterior distributions (Bolstad and Curran
2016).
In this thesis, we consider minimal informative and conjugate priors.
2.4.2 Posterior Distribution
Using Bayes’ theorem, we can compute the posterior probability distribution (conditional distribution of the
uncertain quantity given the data) by taking the product of the prior and the likelihood function. Thus,
applying Bayes’ theorem the posterior distribution of unknown quantity (θ) given data (y) can be defined
as (Van et al. 2014)














is known as the normalizing constant of the posterior distribution. Moreover, the likelihood function
L(θ) is a function proportional to p(y|θ), i.e., L(θ) ∝ p(y|θa). Posterior mean from the sample Xt can be






Bayesian inference is based on the posterior distribution of the parameters given the data (Van et al.
2014). Because the posterior density is an actual probability density, one way to do this is to sample values
from the distribution and then to compute the sample statistics. The posterior density of a parameter
describes its behavior over a range of values (the support of the parameter space). We generate a sample of
values from the posterior distribution and then use these values to approximate posterior means or median,
standard deviations, and 95 % credible intervals, or any other quantity of our interest.
Bayesian Point Estimates
The approximated posterior mean or median is considered as the point estimate of the parameter of interest
(Van et al. 2014). When computing a Bayesian point estimate, we want to find a single value that conveys
information about the centre of the posterior distribution, i.e. what value of the parameter is most likely in
some sense. The two commonly used point estimates for the parameters of the model are; posterior mean
and the posterior median (the mean and median of the posterior density). Moreover, these values are easier
to compute even in complicated problems (Bolstad and Curran 2016).
Posterior Standard Deviation
The posterior standard deviation in the Bayesian approach is equivalent to the standard error of frequentist
methods. As the name implies, it is the standard deviation of the posterior density. However, the interpre-
tation of these two values is quite different. The posterior standard deviation is a direct statement about the
uncertainty in the true value of the parameters and the standard error is a statement about the uncertainty
of the estimated value of parameters (Bolstad and Curran 2016).
Credible Intervals
In Bayesian inference, the equivalent of the confidence interval is the credible interval. Its main purpose is
to describe and summarize the uncertainty related to the parameters. A credible interval is an interval in
which an unobserved parameter has a given probability. In confidence intervals, we also treat the parameter
as a fixed value, and the bounds are random variables, while in credible intervals, the estimated parameter
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is treated as a random variable while the bounds are considered fixed. A credible Bayesian interval for a
parameter is defined as [cp, c1−p] where cp and c1−p are estimated as the p
th and (1 − p)th quantiles of
the posterior distribution of the parameter, respectively (Van et al. 2014). The posterior density is a true
probability density; we can compute quantiles and percentiles of the parameter.
The simplest credible interval is bounded by the 2.5th and 97.5th percentiles known as 95 % credible
interval. This interval is also called symmetric credible interval because it removes equal probability (2.5 %)
from both tails of the distribution (Bolstad and Curran 2016). We use a 95 % credible interval to check the
significance of the estimated parameters of the model including the significance of association parameter φ
in the joint model. The interpretation of this quantity is that the 95 % credible interval contains the true
value of the parameter. In other words, there is a 95 % probability that the true parameter value lies in the
credible interval.
We can estimate all the exact posterior estimates if we know the posterior distribution of our interest. The
determination of posterior distribution contains the calculation of complex and multi-dimensional integrals.
Such problems arise in both frequentist and Bayesian approaches (Geyer and Thompson 1995, Christensen
2004). For example, when computing the normalizing constant and marginal posterior distribution integra-
tion for a particular parameter or a vector of parameters of interest from the posterior, models become too
difficult to analyze analytically. Then we need simulation algorithms like MCMC. The MCMC method is
commonly used to solve the complexed integration problem and to calculate posterior estimates. All of the
Bayesian processes rely on MCMC.
2.5 MCMC Methods and Diagnostics
Markov Chain Monte Carlo (MCMC) method is particularly useful in Bayesian inference because of the focus
on sampling from posterior distributions, which are often difficult to work with via analytic examination. A
Markov chain is a sequence of events whose distribution depends only on the outcome of the previous event.
MCMC allows to approximate aspects of posterior distributions that cannot be directly calculated. The
essential feature in MCMC methods is, if the simulation algorithm is implemented correctly, the Markov
chain has the guarantee to converge to the targeted distribution. In other words, a Markov chain improves
its approximation to the accurate underlying distribution at each step in the simulation. The properties of
the Markov chain are discussed in detail by Meyn and Tweedie (2012), Feller (1957) and Breiman (1968).
Non-measure-theoretic treatment of all stochastic processes including Markov chains was proposed by Pekoz
(1997) and Karlin and Taylor (1975).
Bayesian inference is based on Monte Carlo samples (MCMC) drawn from the posterior distribution
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using an MCMC algorithm such as the Gibbs sampler (Givens and Hoeting 2005) or Metropolis-Hastings
(Hastings 1970). The MCMC method is a typical simulation method for consecutive sampling from poste-
rior distributions and computing posterior quantities of interest from a targeted distribution. Each sample
depends on the previous sample. Monte Carlo integration is generally used to approximate the expectation
by using the Markov chain samples. There are several techniques to construct Markov chains, including the
Metropolis-Hastings algorithm and Gibbs sampling(Givens and Hoeting 2005). The MCMC simulation was
first proposed in the literature of physics. Metropolis and Ulam (1949) and Metropolis et al. (1953) explain
the well-known Metropolis algorithm and used it to produce sequences of samples from the joint distribution
of multiple variables. The generalized work on the Metropolis-Hastings algorithm was done by Hastings
(1970), resulting in the Gibbs sampling algorithm.
In our implementation for Bayesian inference, we consider MCMC methods with the Gibbs sampler
technique (Givens and Hoeting 2005). From the MCMC method, we create samples from an arbitrary
posterior density, then use these samples to approximate expectations of quantities of interest.
Gibbs Sampler
The name of Gibbs sampler algorithm was proposed by Geman and Geman (1984) and they initially applied
it to analyze image data. The Gibbs sampling technique was first used by Gelfand et al. (1990) to solve
the problem in the Bayesian approach. Under the formation of Gibbs sampling, the parameter vector is
decompose into a number of components of possibly differing dimensions, and then each of these components
is updated one by one. For a particular component, an instance of a Markov chain is generated from its full
conditional distribution and create sample from them.
The Gibbs sampler algorithm works as follows (Zhao et al. 2008):
1- Choose an arbitrary initial value of θ(0) = (θ
(0)
1 , ......, θ
(0)
k at t= 0.






















1 , ........, θ
(t+1)
k−1 , y).
3- Set t = t+ 1 If t < T , the number of desired samples, return to step 2. Otherwise, stop.
2.5.1 MCMC Performance
Whenever Markov chains are run, it is important to assess the performance of these chains. It is suggested
that at least two chains are run to analyze MCMC output. Important features to assess the performance of
Markov chains are describes below.
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MCMC Mixing
The efficiency of an MCMC algorithm depends on its mixing ability. The mixing property of a chain refers
to two characteristics. First, how quickly a chain forgets its initial values. Second, how quickly a chain can
explore the full support and shape of the target distribution (Cowles and Carlin 1996).
Number of Chains
There are conflicting arguments in the literature regarding the selection of the number of chains to be used
in the MCMC algorithm. Some scholars (Gelman and Rubin 1992) suggest several long chains, while others
(Geyer 1992) recommend only one and long chain. Gilks et al. (1995) and Givens and Hoeting (2005)
discussed the advantages and disadvantages of each method. The main idea is that the chain can reach
around the mode of the target distribution and can stay there forever, even for a very long chain. In such
a case, the convergence diagnostic may indicate the convergence of the chain, although the chain does not
fully explore the support and shape of the target distribution. On the other hand, running multiple chains
can ensure that at least one of them will explore the features of the target distribution and will wash out the
influence of initial values. Usually, in practice, two or more chains are run with the idea that at least one of
these chains converge to the targeted distribution and explore all the feature related to that distribution. In
order to implement MCMC for our joint models, we construct two Markov chains that necessarily converge
to an underlying stationary distribution.
Burn-in and Stopping Time
The dependence of a Markov chain on its starting value may remain stable even after the chain has been run
for a long period. As a consequence, if the chosen initial values are far different from the posterior mode,
this dependency may make the chain converge slowly (Cowles and Carlin 1996). It may take some iterations
for the chains to enter into the high probability region where they are more representative of the target
distribution. In practice, initial S iterations are discarded as a burn-in period to make the chain independent
of its starting values and converge quickly to the target distribution (Gelman 1996). Typically, a chain
should be stopped at a particular time after running the chain for a sufficiently long period to obtain good
mixing. In practice, it is difficult to decide about the stopping time. Gilks et al. (1995) suggested an informal
way of determining the stopping time to run several long chains and to compare the estimates (posterior
means/medians) from each chain. If the estimates produced by different chains do not agree closely, then
the run length should be increased.
Thinning
The slow decay of autocorrelation generally exhibits poor mixing of a chain. It is, therefore, a good practice
that the inference should be based on every ith iteration of chains, with i set to some value high enough that
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successive draws are approximately independent (Gelman 1996). This strategy is known as thinning in the
literature.
MCMC Convergence
However, it is often difficult to decide at what point it would be reasonable to believe that the samples are
accurately approximate the underlying stationary distribution of the Markov chain. The convergence of a
chain is to check how efficiently the chain has approximated to its stationary distribution (Cowles and Carlin
1996). To determine the convergence of the chains, formal test statistics, Gelman-Rubin R statistic (Gelman
and Rubin, 1992), is a very popular and useful technique. This statistic is based on the comparison of
within-chain and between-chain variances. Values of R substantially above 1 indicate a lack of convergence.
Some authors suggest that R < 1.2 is acceptable (Brooks and Gelman 1998). We use formal test statistics,
the Gelman-Rubin R statistic (Gelman and Rubin 1992) technique to check the convergence of the two
Markov chains.
Graphical Tools
Convergence and mixing property of a chain can also be examined through three widely used graphical tools:
trace plot, autocorrelation plot and density plot (Gelman 1996). Trace plots show how rapidly the chain is
mixing. Trace plot is the realization of the chains versus the iteration number. A well-behaved chain will
move away from its starting values quickly, no matter where it started and the samples will wiggle about
vigorously in the supported region by the posterior density indicating no specific trend seen between two
chains (Givens and Hoeting, 2005). If a clear trend is seen in the trace plot, suggests that there is a lack of
good mixing in chains and stationary distribution has not achieved.
An autocorrelation plot shows the serial correlation in the chain at different lags of iteration (Givens and
Hoeting, 2005). In general, the autocorrelation decreases as the lag increases. If the situation is different,
thinning should be explored. A density plot is a smoothed histogram of the MCMC samples used to approx-
imate the posterior density. Smooth kernel density plots indicate the samples are accurately approximate
the underlying stationary distribution of the Markov chain (Gilks et al. 1995).
In the presence of high autocorrelation, convergence is not guaranteed and indicating that the distribution
is multimodal (Cowles and Carlin 1996). We can see that multimodality by kernel density plots with multiple
modes and lumpiness rather than a smooth curve. It is to be noted that such behaviour in the density plots
may result due to high autocorrelation within a converged chain. In such cases, severity can be reduced by
running the chain for a longer time or with heavier thinning (Gelman 1996). We use trace plots and density
plots to check the good mixing and convergence of both chains in our analysis.
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2.5.2 Model Selection Criterion
The most common way to compare the fit of two different models is the likelihood method, compare the
values of the likelihood evaluated at the parameter estimates. The model with the larger likelihood fits the
data better than the model with a smaller likelihood value. However, the likelihood value always increases
when more parameters are added to the model. Therefore, considering the likelihood alone for the selection
of the model is not appropriate, it always selects the model with the most parameters. Instead, we want to
choose the model according to the principle of parsimony, which provides the best fit to the data with the
less number of parameters.
There are many model selection criteria in Bayesian analysis, derived based on a variety of principles.
These include deviance information criterion (DIC) (Spiegelhalter et al. 2003), BIC or the Schwarz criterion
(Schwarz et al. 1978), and Watanabe-Akaike information criterion (WAIC) (Watanabe 2010). DIC is the
most widely used tool for model comparison in Bayesian analysis (DIC, Spiegelhalter et al. 2003). It does
not require maximization over the parameter space, like the AIC and BIC. A smaller DIC indicates a better
fit to the data set.
DIC is one of the ways to select the most parsimonious model. It creates a balance between the likelihood
and the number of parameters in the model. It is computed from (a) the deviance which is obtained by
the minus twice of the value of the log of the likelihood; deviance plays a vital role in classical statistics (b)
then added an estimate of the number of unique and estimable parameters in the model, called the effective
number of parameters. DIC involves posterior mean that takes into account prior information and penalized
likelihood. DIC can be computed as (Spiegelhalter et al. 2003)
DIC = E[D(θ|data)] + pD. (2.26)
The first part of left hand side of the equation (2.26) presents the estimated value of Deviance statistics
= −2 log (likelihood(θ|data)) and is used to measure the goodness of fit for the model and the second part
presents effective number of parameters (pD) . The DIC is a Bayesian alternative to the other two widely
used criteria; Akaike’s information criterion (AIC) and Bayesian information criterion (BIC) (Robert 2007
and Spiegelhalter et al. 2003).
Since deviance has the opposite sign to the likelihood. Therefore, the best fitting model will be the one
with the lowest DIC (i.e., the highest penalized likelihood). In practice, the value of the DIC varies for a
given model because of error in the MCMC sampling and noise in the data. If the difference in DIC values
between the two models is > 10, then the model with a smaller value of DIC is preferred (Raftery 1995). In
general, if the difference in the values of DIC of two models is five or more than five (preferably is greater
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than 10) (http://users.jyu.fi/ ∼ hemipu/itms/DIC%20web%20site%20from%20BUGS%20project.pdf ), then
it presents clear evidence in favour of the model with lower DIC value on the other model with high DIC
value. Note that if differences between DIC values of two model is less than five, then it provides weaker
evidence to choose one model over the other model based on low DIC value assumption. Smaller differences
may be the result of random variation and should not be considered as a support for one model over another.
Furthermore, DIC has several applicable properties, including that it can be calculated when non-
informative or improper priors are used. Moreover, DIC can be easily computed using MCMC simulation
implemented in the WinBUGS software. In this thesis, we consider DIC as a criterion for the comparison of
our suggested models.
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3 Joint Models of Accelerated Failure time and
Longitudinal Data
Joint models and joint model analysis using maximum likelihood estimation (MLE) method were dis-
cussed in Chapter 2. In this chapter, we will present the formulation of our proposed joint models of
longitudinal and time-to-event data using the log-logistic and Weibull AFT models. We adopt the approach
of Hederson et al. (2000) to formulate the model, where the two processes are linked through stochas-
tic dependence (Gamerman and Lopes 2006). A Bayesian approach is considered for statistical inference,
implemented in the statistical software WinBUGS (Lunn et al. 2000).
3.1 Notation
For completeness of this chapter, we re-introduce our notation in this section. Let there be n subjects
with lifetimes denoted by T1, T2, . . . , Tn. Assuming that the data are subject to right censoring, we observe
ti = min(Ti, Ci), where Ci > 0 corresponds to a potential censoring time for subject i. Letting δi = I(Ti ≤ Ci)
that equals 1 if Ti ≤ Ci and 0 otherwise, the observed data for individual i consist of {ti, δi, zi}, i = 1, 2, . . . , n,
where ti is a lifetime or censoring time according to whether δi = 1 or 0, respectively, and zi is a p×1 vector
of covariates. Also, assume that the ith subject provides a set of longitudinal quantitative measurements
{yij , j = 1, 2, . . . , ni} at times {sij , j = 1, 2, . . . , ni}, and θ denotes the full parameter vector.
3.2 Longitudinal Sub-model
We model the longitudinal response yij at time sij by the relationship (Hederson et al. 2000)
yij = µi(sij) + Ui(sij) + εij , (3.1)
where µi(sij) is the mean response, Ui(sij) incorporates subject-specific random effects, and εij ∼ N(0, σ2)
is a sequence of mutually independent measurement errors. We assume that the mean response at time s is





where xi(s) is a vector of covariates (possibly time-dependent) and α is the corresponding vector of regression




where wi(s) is the design vector for the random effects bi ∼ N(0,Σb).
3.3 Survival Sub-model
We consider an AFT model to describe the event hazard process at time t (Cox and Oakes, 1984), expressed
as
hi(t) = h0(gi(t)) exp(−z′iβ − Vi(t)), (3.4)
where h0(·) is the baseline hazard function, gi(t) =
∫ t
0
exp(−z′iβ − Vi(u))du, zi is a vector of baseline
covariates with a corresponding vector of regression coefficients β, and Vi(t) is specified in a similar way to
Ui(t). Note that zi may or may not have elements in common with xi of the longitudinal model. Under this
setup, the probability density function and the survival function can be written as
fi(t) = f0(gi(t)) exp(−z′iβ − Vi(t)), (3.5)
and
Si(t) = S0(gi(t)), (3.6)
where f0(·) and S0(·) are the baseline probability density function and the baseline survival function, respec-
tively.
3.4 Association Structure
In our implementation, dependence between the longitudinal and the time-to-event sub-models is captured
through Vi(t) = φUi(t) so that φ is a measure of association induced by the fitted longitudinal values.
Although association via longitudinal values is the most common way to formulate a joint model, the as-
sociation structure can also be modeled using random intercepts or random slopes. Hederson et al. (2000)
discussed such association structures for PH models. Addressing the association via random intercepts or
random slopes for AFT models could be an area of future research.
3.5 Example: Log-Logistic Sub-Model
Using equation (3.4) and Vi(t) = φUi(t) = φw
′










exp(−z′iβ − φw′i(u)bi)du and h0(gi(ti)) = κρ(ρgi(ti))κ−1/[1 + (ρgi(ti))κ]. Similarly, the
survival function can be expressed as
Si(ti) = S0(gi(ti)) = [1 + (ρgi(ti))
κ]−1. (3.8)






× [1 + (ρgi(ti))κ]−1, (3.9)
which plays an important role in formulating the joint model in a Bayesian framework (see Section 3.7).
3.6 Example: Weibull Sub-Model
Using equation (3.4) and Vi(t) = φUi(t) = φw
′
i(t)bi, the hazard function at time ti can be written as
hi(ti) = κρ(ρgi(ti))




exp(−z′iβ− φw′i(u)bi)du and h0(gi(ti)) = κρ(ρgi(ti))κ−1. Similarly, the survival function
can be expressed as
Si(ti) = S0(gi(ti)) = exp[−(ρgi(ti))κ]. (3.11)




κ−1 exp(−z′iβ − φw′i(ti)bi)
}δi
× exp[−(ρgi(ti))κ], (3.12)
which plays an important role in formulating the joint model in a Bayesian framework (see Section 3.7).
3.7 Joint Model: A Bayesian Approach
Our choices of distributions for the relevant quantities allow us to write the joint model as














[α|µα,Σα] ∼ N(µα,Σα), [β|µβ ,Σβ ] ∼ N(µβ ,Σβ),













where the hyperparameters Ψ, ν, µα, Σα, µβ , Σβ , a0, a1, b0, b1, c0, c1, d0 and d1 are all assumed known.
Some remarks are necessary for the hierarchical formulation (equation 3.13).
1. Gauss-Legendre 5-point quadrature rule (Abbott 2005) is used to evaluate the integral gi(ti) in log f(ti, δi|bi,θ)
(see Appendix B).
2. The so-called “zeros-trick” (Spiegelhalter et al., 2003) is used to specify the distribution of (ti, δi), as
it is not of a standard form. The idea behind this technique is that the contribution of a Poisson(ξ)
observation of zero is exp(−ξ); if we set ξi = − log f(ti, δi|bi,θ), i = 1, 2, . . . ,m, with observed data a
vector of 0’s, then we get the correct contributions.
3. For the gamma and Wishart distributions, we consider the parameterizations implemented in the
WinBUGS software (Lunn et al. 2000). For example, b0 and b1 are the shape and inverse-scale
parameters of the Gamma(b0, b1) distribution, respectively, and Ψ and ν are the inverse-scale matrix
and degrees of freedom of the Wishart distribution Wishart(Ψ, ν), respectively.
3.8 Software Implementation
The MCMC algorithm is implemented in WinBUGS (Lunn et al. 2000) using fairly vague, minimally infor-
mative priors. For example, α is assumed to follow a multivariate normal distribution with mean zero and
variance-covariance matrix Σα, where Σα is a diagonal matrix with all the diagonal elements equal to 10
5.
For a gamma prior, for example [σ−2|b0, b1] ∼ Gamma(b0, b1), we take b0 = b1 = 0.1.
Note that the statistical software R is used for data manipulation and organization. The R2WinBUGS
package in R (R Core Team 2018) is then used to run WinBUGS (Lunn et al. 2000) from R for MCMC
samples, and the coda package (Plummer et al., 2006) is used for summarizing and plotting MCMC output.
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4 Data Analyses
Our proposed methodology is illustrated with an application to aortic valve replacement surgery data.
The description of the data is presented in Section 4.1, and the variables of interest and the goal of the study
are highlighted in Section 4.2. We then present the analysis of the data using our proposed methodology in
Section 4.3. A conclusion of our findings is given in Section 4.4.
4.1 Aortic Valve Replacement Surgery Data
The aortic heart valve replacement surgery data are publicly available in the joineR package (Philipson et
al. 2018) of the statistical software R (R Core Team 2018). This is a longitudinal data set collected from
an observational study. In this study, different types of heart valves were implanted on the aortic positions
with the goal to detect their effects on survivals of the patients.
The study received ethical approval from the chairman of the ethics committee; note that the committee
members decided to waive the need for patient consents (Lim et al. 2008). Data were collected from con-
secutive series of patients who underwent aortic valve replacement surgery performed by a single surgeon
from 1991 to 2001. In this series, the predominant stentless valve used for the aortic valve replacement was
Toronto stentless porcine valve followed by homograft valve. Moreover, Ali et al. (2003) discuss the detail
of the surgical procedure used for the implementation of stentless and homograft valve.
The total number of patients who participated in the study was 256 and all the patients were studied
for ten years from the year 1991 to the year 2001 with at least one year of follow-up with a serial total
of 1,273 echocardiographic measurements. Echocardiography was performed on an annual basis. Patients
who underwent two or more procedures were censored from the time point of the second procedure to en-
sure that every patient was analyzed only once. The study leads to the fact that three heart valve functions
are associated with the improvement of survival of patients with a stentless or a homograft valve replacement.
The three heart valve functions are described as
• grad: valve gradient at follow-up visit
• lvmi: left ventricular mass index (standardized) at follow-up visit
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• ef: ejection fraction at follow-up visit
In this thesis, for the longitudinal process, we consider log.lvmi (natural logarithm transformation of lvmi)
as a longitudinal outcome (internal covariate) .
The collected dataset is unbalanced; all the subjects do not have the same number of observations.
Moreover, along with the longitudinal outcomes, there are several baseline covariates available and also, the
information about survival data is available. Demographic, preoperative, and mortality data were obtained
from individual hospital notes, death certificates, and autopsy reports.
4.2 Study Variables of Interest
Recall that our objectives of this thesis are; developing joint models using AFT event processes, writing
the model in a hierarchical framework for Bayesian implementation, developing computational algorithms
to fit joint models, implemented in WinBUGS (a Bayesian software) and R and finally to analyze the aortic
valve data using our approach and investigate the effects of baseline covariates on both the longitudinal
response and the event process. In the subsequent sections, first, we describe the variables of our interest,
then describe the proposed joint models based on data and finally present and discuss the results from the
analysis of the aortic valve data.
4.2.1 Longitudinal Outcome
log.lvmi: Natural log transformation of left ventricular mass index (standardized) at follow-up
visit
log.lvmi is a continuous variable and defined as
lvmi = (left ventricular mass) / (body surface area)
Left ventricular mass (LVM) was calculated from M-mode recordings with measurement unit is grams and
indexed to body surface area, which is measured in meters2.
LVMI is calculated in two steps (for more detail, see Lim et al. 2008), first LV mass is computed by using
the following formula,
LV mass = 1.o4([IVSd + LVIDd + PWTd]
−3 − [LVIDd]3)− 13.6.
where LV mass is left ventricular mass in grams, IVSd is end-diastolic interventricular septum, LVIDd is
end-diastolic left ventricular internal diameter, PWTd is enddiastolic posterior wall thickness. Then LV
mass was indexed to body surface area which resulted in the left ventricular mass index (LVMI).
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4.2.2 Longitudinal Time-varying Covariate
time: follow-up time
“Time” is a continuous variable measured in the number of years, the time values are obtained from observed
time points (follow-up time points). Surgery date is considered as the time of origin (years).
4.2.3 Survival Outcome
status: censoring indicator
The variable “status” indicates, either the event (death) occurs or not. It is a categorical variable with two
categories. We coded this variable in the analysis as
status(δ) =
1 if died0 if lost to follow up (4.1)
where the status “0= lost to follow up” is considered as the reference category.
fuyrs: event time
“fuyrs” is a continuous variable and provides us with the information about maximum follow-up time (years)
with surgery date as the time of origin. This variable contains information about the time of occurrence of
the event for the analysis of our study.
4.2.4 Longitudinal and Survival Baseline Covariates
hs: implanted aortic prosthesis type
In this study, the baseline covariate “hs” provides us with information about the type of heart valve implanted
during surgery based on tissue type. Evidence from the literature concludes that the choice of the type of
heart valve is a significant factor associated with the risk of death after the aortic heart valve replacement
surgery and also has an impact on the life expectancy of the patient (Siniawski et al. 2003 ). We investigate
the effects of hs on log left ventricular mass index (log.lvmi) and the risk of death.
hs is a categorical variable with two categories and we coded hs as
hs =
1 if homograft0 if stentless procine tissue (4.2)
where “0 = stentless porcine tissue” is considered as the reference category.
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lv: preoperative left ventricular ejection fraction (LVEF)
About the impact of lv for the risk of death after valve surgery, literature has inconsistent conclusions
(Forman 1980, D’Onofrio et al. 2017, Goldberg et al. 2013 and Gaudino et al. 2004 ). We investigate the
effects of “lv” on internal covariate loglvmi and the risk of death after valve replacement surgery. “lv” has
three categories, we consider “3=poor” as the reference category and create two dummy variable (lv1 and
lv2). We use the following coding for lv in the analysis.
lv1 =
1 if good0 if otherwise (4.3)
lv2 =
1 if moderate0 if otherwise (4.4)
redo: previous cardiac surgery
Information collected from the hospital notes about the patient with previous cardiac surgery was named as
“redo”. It is a categorical variable and has two categories.
Previous cardiac surgery (redo) is considered as an important factor for long term survival after valve
replacement surgery (Shehada et al. 2017). We investigate the association of “redo” on log.lvmi as well as
on the risk of death in the study. We coded redo as
redo =
1 if Yes0 if No previous cardiac surgery (4.5)
where “0= No previous cardiac surgery” is the reference category.
dm: preoperative diabetes
Information collected about the patient with preoperative diabetes was named as “dm”. It is a categorical
variable and has two categories. Study shows that the patient with preoperative diabetes is associated with
significantly worse outcomes after valve replacement operation (Nakamura et al. 2016). We investigate the
effects of preoperative diabetes (dm) on log.lvmi as well as on the risk of death. We use the following coding
for “dm”,
dm =
1 if has diabetes0 if has no dibetes (4.6)
where “0= has no diabetes” is the reference category.
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age: age of the patient at day of surgery (years)
“age” is a continuous variable. Results from the literature showed, age has a strong association with lvmi
(Villa et al. 2006 and Nakamura et al. 2016) as well as on the survival rate (Langanay et al. 2012 and Tjang
et al. 2007) after heart valve replacement surgery. We investigate the association of age on log.lvmi and the
risk of death.
sex: gender of patient
The impact of “sex” has been identified to influence the left ventricular mass regression (Villa et al. 2006),
and also has an impact on survival (Kulik et al. 2009) after heart valve surgery. We investigate the effects
of sex on loglvmi as well as on the risk of death after aortic heart valve replacement surgery. In the analysis,
we coded “sex” as,
sex =
1 if Female0 if Male (4.7)
Male is considered a reference group.
4.2.5 Model Building Based on Data
The formulation of our longitudinal sub models is already discussed in section 3.2 of this thesis. Here we will
implement this formulation according to our data. Let yij denote the logarithm of j
th left ventricular mass
index (log.lvmi) for patient i, i = 1, 2, . . . , n, and j = 1, 2, . . . , ni. Then the linear mixed-effect model for the






ijbi + εij , (4.8)
where
x′ijα = α1 + α2 timeij + α3 hsi + α4 lv1i + α5 lv2i + α6 redoi + α7 dmi + α8 agei + α9 sexi, (4.9)
and
w′ijbi = bi0 + bi1 timeij . (4.10)
Recall that joint density functions for both proposed survival sub-models given bi and θ including shared






















exp(−z′iβ − φw′i(u)bi)du. (4.14)
Note that the integration described in equation (4.14) has no closed form solution. Therefore, we use the
5-point Gauss-Legendre Quadrature rule (Abbott 2005) to solve this Integration (for more detail about
Gauss-Legendre Quadrature rule, see Appendix B ).
4.3 Data Analysis and Results
In this section, first, we present the descriptive analysis, then we present and discuss the results of both
proposed Bayesian joint models (described in chapter 3).
4.3.1 Descriptive Statistics
Table 4.1 presents a descriptive analysis of all the categorical and continuous variables of interest from
the study. Descriptive analysis (Table 4.1) shows till at the end of the study, only 54 (21.09 %) patients
experience the event (death) and 202 (78.91 %) patients either lost the follow-up or did not experience the
event (censored observations). Stentless porcine tissue type valve was implanted in 48.05 % of the patients
and 51.95 % patients ’ heart valve was replaced by homograft type valve. The average measurement of
log.lvmi was 5 gm/m2 (S.D = 0.38) and the average age of the patients who participated in the study was
66 years (S.D = 12.37). The mean follow-up time was 3.14 years (S.D = 2.47) and the mean survival time
was 5.32 years (S.D = 2.52) after aortic heart valve replacement surgery. Moreover, among 256 patients who
participated in the study, approximately 71 % were male and 29 % were female.
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Table 4.1: Characteristics of categorical and continuous variables of heart valve data (N
= 256)
Categorical Variables levels Frequency (%)
status (survival response)
lost at follow up 202 (78.91 %)
died 54 (21.09 %)
hs
stentless porcine tissue 133 (51.95 %)
Homograft 123 (48.05 %)
lv
good 147 (57.42 %)
moderate 87 (33.98 %)
poor 22 (8.59 %)
redo
no previous cardiac surgery 230 (89.84 %)
have orevious cardiac surgery 26 (10.16 %)
dm
no diabetes 244 (95.31 %)
has diabetes 12 (4.69 %)
sex
Male 183 (71.48 %)
Female 73 (28.52 %)
Continuous Variables Mean Standard Deviation
log.lvmi (longitudinal response) 5.00 0.38
time: Follow up time 3.14 2.47
fuyrs: time (survial response) 5.32 2.52
age 66.00 12.37
4.3.2 Results from Log-Logistic AFT (Model 1) and Weibull AFT (Model 2)
in Bayesian Joint Model Fits
We implement MCMC methods to check the efficiency of both proposed Bayesian joint models in the analysis.
For the MCMC method, the simulation of the posterior distribution is made using the Gibbs sampler
algorithm. First, we construct two Markov chains to approximate the posterior density and produced two
realizations each of 150,000 iterations. A burn-in of 15,000 iterations is considered, i.e., we discarded the
initial 15,000 iterations to get the good mixing and convergence of chains. Moreover, the Bayesian inferences
of our models are based on every 5th iteration of the chain called thinning (Gelman 1996). From the thinning
process, we get 27,000 total number of iterations (sample size) for each chain. MCMC diagnoses are also
assessed. Diagnostic assessment of MCMC usually implies from the graphical assessment (Roy 2019) of the
behaviour of the sample with respect to each fitted parameter.
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(a) Intercept (b) time (c) hs
(d) lv1 (e) lv2 (f) redo
(g) dm (h) age (i) sex
(j) σ−2
Figure 4.1: Trace plots of longitudinal sub-model parameters in Bayesian joint log-logistic AFT
model fit.
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(a) Intercept (b) time (c) hs
(d) lv1 (e) lv2 (f) redo
(g) dm (h) age (i) sex
(j) σ−2
Figure 4.2: Density plots of longitudinal sub-model parameters in Bayesian joint log-logistic AFT
model fit.
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(a) hs (b) lv1 (c) lv2
(d) redo (e) dm (f) age
(g) sex (h) shape=κ (i) rate=ρ
(j) Association=φ
Figure 4.3: Trace plots of log-logistic AFT survival sub-model parameters in Bayesian joint model
fit.
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(a) hs (b) lv1 (c) lv2
(d) redo (e) dm (f) age
(g) sex (h) shape=κ (i) rate=ρ
(j) Association=φ
Figure 4.4: Density plots of log-logistic AFT survival sub-model parameters in Bayesian joint model
fit.
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(a) Intercept (b) time (c) hs
(d) lv1 (e) lv2 (f) redo
(g) dm (h) age (i) sex
(j) σ−2
Figure 4.5: Trace plots of longitudinal sub-model parameters in Bayesian joint Weibull AFT model
fit.
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(a) Intercept (b) time (c) hs
(d) lv1 (e) lv2 (f) redo
(g) dm (h) age (i) sex
(j) σ−2
Figure 4.6: Density plots of longitudinal sub-model parameters in Bayesian joint Weibull AFT model
fit.
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(a) hs (b) lv1 (c) lv2
(d) redo (e) dm (f) age
(g) sex (h) shape=κ (i) rate=ρ
(j) Association=φ
Figure 4.7: Trace plots of Weibull AFT survival sub-model parameters in Bayesian joint model fit.
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(a) hs (b) lv1 (c) lv2
(d) redo (e) dm (f) age
(g) sex (h) shape=κ (i) rate=ρ
(j) Association=φ
Figure 4.8: Density plots of Weibull AFT survival sub-model parameters in Bayesian joint model
fit.
MCMC Diagnostics of Bayesian Joint Model 1 (section 3.5)
Trace plots of each estimated parameter for longitudinal and log-logistic AFT survival sub-model in Bayesian
joint model fit are presented in Figure 4.1 and Figure 4.3, respectively. These trace plots exhibit rapid up-
and-down variation with no long-term trends or drifts. The lack of any trend in the trace plots of both
chains, indicating chains forget their initial values very quickly and quickly explore the full support and the
shape of the targeted distribution. It also indicates that the convergence in targeted distribution takes place
45
rapidly. Thus, we have good mixing and convergence of both chains.
Density plots of each estimated parameter for longitudinal and log-logistic AFT survival sub-model in
Bayesian joint model fit are presented in Figure 4.2 and Figure 4.4, respectively. From these plots, we
see the smooth kernel density functions without any lumpiness and multiple modes, indicating no sign of
multimodality. Therefore, the samples accurately approximate the underlying stationary distribution of the
Markov Chain.
MCMC Diagnostics of Bayesian Joint Model 2 (section 3.6)
Trace plots of each parameter for longitudinal and Weibull AFT survival sub-model in Bayesian joint model
fit are presented in Figure 4.5 and Figure 4.7, respectively. Similar to joint model 1 trace plots (Figure 4.1
and Figure 4.3), these trace plots also exhibit rapid up-and-down variation with no long-term trends or
drifts. The lack of any trend in the trace plots of both chains, indicating chains forget their initial values
very quickly and quickly explore the full support and the shape of the targeted distribution. It also indicates
that the convergence in distribution takes place rapidly. Thus, we have good mixing and convergence of
both Markov chains.
Density plots of each parameter for longitudinal and Weibull AFT survival sub-model in Bayesian joint
model fit are presented in Figure 4.6 and Figure 4.8, respectively, We see the smooth kernel density func-
tions without any lumpiness and multiple modes like the density plots for joint model 1 (Figure 4.2 and
Figure 4.4,), indicating no sign of multimodality. Therefore, the samples accurately approximate the under-
lying stationary distribution of both Markov Chains.
Moreover, the formal test statistics known as Gelman-Rubin statistic also suggests good mixing and
convergence of the chains for both joint models, the value of statistics for all the parameters and quantities
of interest is less than 1.2 and approximately equal to one (see Appendix C).
We present the interested posteriors summaries of all the parameters of log-logistic AFT (model 1) and
Weibull AFT (model 2) in the Bayesian joint model fits in Table 4.2.
Results from Bayesian joint model 1 (Table 4.2)
The results of longitudinal process for Bayesian joint log-logistic AFT model show that the overall mean in
the longitudinal process is significant with estimates 5.240 and 95 % credible interval (4.950, 5.532). The co-
variates having statistically significant effects on log transformation of left ventricular mass index (log.lvmi)
measurement are: patient with preoperative diabetes (dm) with an estimate of -0.199 and excluding 0 in
95 % credible interval (-0.390, -0.009) and sex (female) with an estimate of -0.162 and excluding 0 in 95
% credible interval (-0.254, -0.071). Other covariate including the follow-up time (time), implanted aortic
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prosthesis valve based on the type of tissue (hs), the preoperative left ventricular ejection fraction with good
(lv1) and moderate level (lv2) relative to poor level, previous heart surgery (redo) and age of the patient
have no significant effect on log.lvmi measurements (Table 4.2: 95 % credible interval for all the parameters
corresponding to these covariates including 0).
Moreover, the negative sign of the coefficient of preoperative diabetic patients indicates, the diabetic
patients have less log transformation of left ventricular mass index measurement value compares to non-
diabetic patients. Patients with preoperative diabetes have about 18 % (exp (-0.199 ) = 0.82) less value
of log.lvmi measurement compare to non-diabetes patients, after controlling for the other factors. Female
patients are found to have less log transformation of left ventricular mass index measurement value than the
male patients and the value of log.lvmi measurement reduced by about 15 % (exp (-0.162 ) = 0.85) with
time in female patients than the male patients, after controlling for the other factors.
For survival (time to event) process, 95 % credible intervals indicate significant effects for the preoperative
left ventricular ejection fraction (lv) with good level (lv1) compare to poor level and age on the risk of death
(95 % credible intervals for lv1 and age are (0.323, 1.697) and (-0.100, -0.046), respectively, both of which
excluding 0) with an estimate of 0.997 and -0.070, respectively. The covariates; choice of heart valve based
on type of tissue (hs), the left ventricular ejection fraction with moderate level (lv2) compared to the poor
level, previous heart surgery (redo), patient with preoperative diabetes (dm) and sex of the patients have no
significant effect on the risk of death (Table 4.2: 95 % credible interval for all the parameters corresponding
to these covariates including 0).
The estimated value for covariate preoperative left ventricular ejection fraction (lv1) indicates that the
patients with good level of preoperative left ventricular ejection fraction have the high risk of death com-
pared to the patients with poor level of preoperative left ventricular ejection fraction. In the patient with
good level of preoperative left ventricular ejection fraction, the risk of death increase by a factor of 2.7 (exp
(0.997 ) = 2.7) compare to the patient with poor level of preoperative left ventricular ejection fraction, after
controlling for the other factors. After the surgery, one year increase in age reduces the risk of death by
about 7 % (exp (-0.070) = 0.93) after controlling for the other covariates. In other words, we conclude that
the poor level of preoperative left ventricular ejection fraction and age are protective factors for the patients
after aortic valve replacement surgery, after controlling for the other factors.
For joint Log-logistic AFT analysis of time to event and longitudinal processes, 95 % credible interval
quantifies the significance of strong association between longitudinal process ( Internal covariate; log.lvmi)
and the survival process (relative risk of death) as zero does not belong to credible interval (-1.851, -0.16).
Moreover, value of association parameter (φ) indicates, one unit increase in the measurement of Internal
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covariate (log.lvmi) reduces the relative risk of death about 62 % (exp (-0.963) = 0.382), after controlling
for the other factors, i.e., increase value of log.lvm after surgery is a protective factor and helps to increase
the survival of patients after surgery, after controlling for the other factors.
Table 4.2: Bayesian parameters estimations of the proposed joint models fits
Log-Logistic AFT (Model 1) Weibull AFT (Model 2)
(DIC= 240.7) (DIC = 222.2)
Posterior Standard 95 % Credible Posterior Standard 95 % Credible
Parameters mean Deviation Interval mean Deviation Interval
Longitudinal
Process
α1 (Intercept) 5.240 0.149 4.950, 5.532 5.239 0.147 4.950, 5.526
α2 (time) -0.008 0.005 -0.018, 0.002 -0.008 0.005 -0.018, 0.002
α3 (hs) -0.067 0.047 -0.159, 0.024 -0.066 0.047 -0.157, 0.026
α4 (lv1) -0.123 0.075 -0.270, 0.024 -0.125 0.075 -0.273, 0.023
α5 (lv2) -0.133 0.078 -0.287, 0.019 -0.136 0.078 -0.289, 0.015
α6 (redo) 0.049 0.072 -0.090, 0.190 0.049 0.070 -0.089, 0.188
α7 (dm) -0.199 0.098 -0.390, -0.009 -0.198 0.097 -0.388, -0.008
α8 (age) -0.0003 0.002 -0.004, 0.004 -0.0002 0.002 -0.004, 0.004
α9 (sex) -0.162 0.047 -0.254, -0.071 -0.162 0.046 -0.252, -0.071
σ−2 26.74 1.560 23.77, 29.88 26.74 1.552 23.80, 29.88
Survival
Process
β1 (hs) 0.044 0.247 -0.430, 0.549 0.069 0.226 -0.366, 0.529
β2 (lv1) 0.997 0.347 0.323, 1.697 0.987 0.322 0.360, 1.637
β3 (lv2) 0.663 0.351 -0.027, 1.359 0.732 0.321 0.099, 1.370
β4 (redo) 0.271 0.433 -0.531, 1.178 0.364 0.403 -0.346, 1.239
β5 (dm) -0.093 0.492 -1.007, 0.941 -0.131 0.462 -0.945, 0.887
β6 (age) -0.070 0.014 -0.100, -0.046 -0.072 0.015 -0.105, -0.046
β7 (sex) 0.016 0.237 -0.440, 0.490 0.043 0.212 -0.360, 0.472
φ(Association) -0.963 0.429 -1.851, -0.16 -0.912 0.408 -1.751, -0.151
κ(shape) 1.652 0.206 1.266, 2.073 1.502 0.193 1.145, 1.900
ρ (rate) 0.002 0.002 0.000, 0.007 0.001 0.002 0.000, 0.006
Results from Bayesian joint model 2 (Table 4.2)
Results from longitudinal process for the Bayesian joint Weibull AFT model fit are similar to the longitudinal
process for the Bayesian joint log-logistic AFT model fit (Table 4.2). Under the Bayesian joint Weibull AFT
model fit from longitudinal process, the results show that the overall mean is significant in the longitudinal
process with estimates 5.239 and 95 % credible interval ( 4.950, 5.526). The covariates having significant
effects on log transformation of left ventricular mass index measurement are: patient with preoperative
diabetes (dm) with an estimate of -0.198 and excluding 0 in 95 % credible interval (-0.388, -0.008 ) and
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covariate sex (female) with an estimate of -0.162 and excluding 0 in 95 % credible interval (-0.252, -0.071).
The covariates, visiting time (time), the choice of heart valve on type of tissue (hs), the left ventricular
ejection fraction with good (lv1) level and moderate level (lv2) compare to poor level, previous heart surgery
(redo), and age of the patients have no significant effect on log.lvmi (Table 4.2: 95 % credible interval for all
the parameters corresponding to these covariates including 0).
Moreover, like joint model1, the negative coefficient of patients with preoperative diabetes indicates, the
diabetic patients have lower log transformation of left ventricular mass index measurement value compare to
non-diabetic patients. At baseline, the diabetic patient have about 18 % (exp (-0.198 )=0.82) less value of
log.lvmi measurement compare to the non diabetes patients after controlling for the other factors. Female
patients have approximately 15 % (exp (-0.162 )=0.85) less value of log.lvmi measurement than the male
patients with the time, after controlling for the other factors.
Our results from the survival process for the Bayesian joint Weibull AFT model fit are similar to the
results of the survival process for the Bayesian joint log-logistic AFT model fit except for the result of pre-
operative left ventricular ejection fraction (lv) covariate with moderate level (lv2) compare to poor level.
Results from survival process show that the covariates having significant effects on the occurrence of event
(death) are: the preoperative left ventricular ejection fraction with good level (lv1) compare to poor level
with an estimate of 0.987 and excluding 0 in 95 % (0.360, 1.637), the preoperative left ventricular ejection
fraction with moderate level (lv2) compare to poor level with an estimate of 0.732 and excluding 0 in 95 %
(0.099, 1.370) and the age of the patient with an estimate of -0.072 and excluding 0 in 95 % (-0.105, -0.046).
The choice of heart valve on type of tissue (hs), previous heart surgery (redo), preoperative diabetes (dm) and
sex of the patients are all not significant predictors associated with the risk of death after valve replacement
surgery (Table 4.2: 95 % credible interval for all the parameters corresponding to these covariates including
0).
The estimated value for the covariates lv1 and lv2 indicate, patient with good level of preoperative left
ventricular ejection fraction (lv1) and the patients with a moderate level of preoperative left ventricular
ejection fraction (lv2) are at a high risk of death after the surgery compared to the patients with poor level
of preoperative left ventricular ejection fraction. Moreover, in the patients with good level of lv the risk of
death increased by a factor of 2.7 (exp (0.987) = 2.7) compare to the patient with poor level of left ventric-
ular ejection fraction, after controlling for the other factors and for the patient with moderate level of left
ventricular ejection fraction the risk of death increased by a factor of 2.1 (exp (0.732 ) = 2.1) compare to the
patient with poor level of left ventricular ejection fraction, after controlling for the other factors. moreover,
after the surgery, one year increase in age reduces the risk of death by about 7 % (exp (-0.072 ) = 0.93),
after controlling for the other covariates.
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For joint Weibull AFT analysis of time to event and longitudinal processes, 95 % credible interval quan-
tifies the significance of strong association between longitudinal process ( Internal covariate; log.lvmi) and
the survival process (relative risk of death) as zero does not belong to the corresponding credible interval (-
1.751, -0.151). Moreover, value of association parameter (φ) indicates, one unit increase in the measurement
of Internal covariate (log.lvmi) reduces the relative risk of death by about 60 % (exp (-0.912)=0.40), after
controlling for the other factors.
Furthermore, the estimated values of ancillary parameters (shape and rate) of both AFT models are: For
log-logistic distribution, the shape parameter estimation is 1.652 with 0.95 credible interval (1.266, 2.073)
and the estimated rate parameter value is 0.002 with 0.95 credible interval (0.000, 0.007). For Weibull dis-
tribution, the estimated shape parameter value is 1.502 with 0.95 credible interval (1.145, 1.900) and the
rate parameter estimation is 0.001 with 0.95 credible interval (1.145, 1.900).
Note that the results of both proposed survival sub-models indicate that the main baseline covariate hs
(implanted aortic prosthesis type of valve; stentless porcine tissue or homograft) is not significantly associ-
ated with occurrence of event (death) (Table 4.2: 95 % credible interval including zero). In other words,
there is no significant difference is seen between the selection of a heart valve for surgery based on tissue type
either stentless porcine tissue or homograft in order to prolong the risk of death after surgery. One possible
reason for this nonsignificant result is, only 21 % patients experience the event (death) until the end of the
study (Table 4.1).
Finally, from the results (Table 4.2), the DIC value for log-logistic fit is 240.7 and the value of DIC for
Weibull fit is 222.2. Therefore, based on DIC values we suggest that the Weibull AFT model perform better
in terms of goodness of fit and the principle of parsimony than the Log-Logistic AFT model for the analysis
of aortic valve replacement surgery data set (Difference in DIC values = 240.7 – 222.2 = 18.5 > 10).
4.4 conclusion
In this chapter, to check the performance of our proposed Bayesian joint models (detail description in
chapter 3) for the longitudinal and survival processes, we implement these proposed models for aortic heart
valve replacement surgery data from joineR package in R software. We create the code for Bayesian approach
and implement it via WinBUGS and R software. Moreover, we can not ignore the joint modelling approach
due to missing observations in the data and association between longitudinal and survival processes.
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5 Discussion/Conclusion
The inspiration of biostatistical research arises from clinical and biomedical studies. The data collected
from these studies have always been getting attention due to their particular features that need special con-
sideration when doing an analysis. New statistical methods have developed over time to handle an analysis
of such data coming from these sources. A typical clinical study often involves collecting repeated measure-
ments on a biomarker (e.g., lvmi measurements) along with an observation of the time to the occurrence of
an event (e.g., death), resulting in a joint modeling setup, a model becomes increasingly popular in clinical
studies.
In general, joint modeling is a collection of statistical methods to properly handle a longitudinal response
while investigating its effects on time to the occurrence of an event simultaneously. (Wulfsohn and Tsiatis
1997 and Tsiatis et al. 1995). Joint models can be formulated with a probability distribution (parametric
models) or without assuming a probability distribution (Cox model or semi-parametric Cox PH model) for
time-to-event process. However, selection for the joint model framework is quite limited in the literature.
The best choice for the selection of longitudinal model can be made based on the observed longitudinal
data, and the best survival model can be selected based on the survival data, using standard model selection
procedures for these models.
Parametric models are pivotal in the joint modeling of longitudinal and time-to-event data. A non-
parametric or semi-parametric model usually leads to an underestimation of standard errors of the param-
eter estimates in the joint analysis (Hsieh et al. 2006, Rizopoulos 2012). Two general classes of models
are in common use for regression analysis of time-to-event data: accelerated failure time (AFT) models
and proportional hazards (PH) models. Parametric PH models are commonly considered to describe the
time-to-event process of joint modeling. An alternative framework involves considering AFT models, which
is particularly useful when the PH assumption is in question. For AFT models, Weibull, Log-logistic, and
Lognormal distribution are widely used parametric models. Weibull distribution is the only distribution
which is closed for both AFT and PH regression models.
In this thesis, we proposed a joint model framework that consists of a continuous longitudinal outcomes
for longitudinal process and a parametric AFT model for time-to-event process and linked both processes
via shared random effects, in which a characteristic of the longitudinal process defined as a function of the
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random effects is included in the survival model (Wulfsohn and Tsiatis 1997).
We developed two Bayesian joint AFT models involving Log-Logistic and Weibull distributions in Chap-
ter 3. We introduced a link between the parametric AFT survival process and the longitudinal process
via one parameter of association (φ) corresponding to shared random effects proposed by Henderson et al.
2000. We also developed algorithms for computationally intensive Bayesian approach and implemented it
via WinBUGS and R software. Finally, standard available software package R2WinBUGS was used to link
WinBUGS and R software for the analysis of aortic heart valve replacement surgery data set. Bayesian
analysis provides inferences that are conditional on the data (Statisticat L. L. C 2015). Unlike frequen-
tist methods, the Bayesian analysis does not depend on asymptotic approximation for statistical inference
(Senn 2003). Availability of software makes Bayesian implementation for complicated models relatively more
straightforward and simple than frequentist methods (involve multiple integrals over random effects).
Analysis was performed with an application to aortic heart valve replacement surgery data (available in
joineR package in R software) to illustrate the performance of our two proposed models (Chapter 3) with
the aim to explore the effect of time-independent and time-dependent covariates on continuous longitudi-
nal outcome (log.lvmi), and comparing the efficiency of two types of valves based on tissue type (Stentless
porcine tissue or Homograft) implanted during surgery and association between internal covariate (longitu-
dinal response: log.lvmi) and the occurrence of an event (death) after the surgery.
From the results (Table 4.2) about the significant effect of the covariates for the longitudinal process of
both suggested joint models concluded that only two covariates, diabetes (dm) and sex were significantly
associated with log transformation of left ventricular mass index (log.lvmi) measurement. Patients with dia-
betic had about 18 % less value of log.lvmi measurement compared to non-diabetes patients, after controlling
for the other factors. Female patients have about 15 % less value of log.lvmi measurement than the male
patients, after controlling for the other factors.
Both survival processes in our analysis showed that the covariates, lv (preoperative left ventricular ejec-
tion fraction) and age of the patients had a significant effect on the risk of death after surgery. The impact
of covariate lv (preoperative left ventricular ejection fraction) on the survival of patients after the surgery
had inconsistent conclusions in the literature (Forman 1980, D’Onofrio et al. 2017, Goldberg et al. 2013,
Tjang et al. 2007 and Gaudino et al. 2004). From a study, the nonsignificant effect of lv was seen in the
survival rate after surgery (Forman 1980 and D’Onofrio et al. 2017). The minimal effect of preserved lv
on postoperative morbidity was noticed and significantly improved survival rate was seen in 6 to 8 years
compared with their a reduced lv (Goldberg et al. 2013). Evidence from some studies showed that reduced
left ventricle ejection fraction was associated with reduced survival rate (Gaudino et al. 2004 and Tjang
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et al. 2007). Our results about lv were different from above-discussed results from the literature and we
concluded that the relative risk of death was increased if the preoperative level of lv is good or moderate
compared to the poor preoperative level of lv.
Form the dataset used in our study, the average age of the patients participated in the study was 66
years and from both models and the results showed that the risk of death decreased by 7 % with one year
increase in the age of patient after aortic heart valve replacement surgery, controlling for other factors. Our
results coincide with the results of the studies in the literature (Sundt et al. 2000, Sharabiani et al. 2016 and
Langanay et al. 2012). According to Sundt et al. (2000), after surgery the late survival rate was good even
in the patients aged greater than 80 years old. Sharabiani et al. (2016) suggested that long-term survival
following surgical AVR in over 65 years old patients was excellent and it was about 8 years more than the
matched general population and from Langanay et al. 2012 results, even in older patients the mortality rate
was low after surgery. Therefore, we suggest that older patients should not be denied surgery due to their
advanced age alone.
Note that, from the survival process of both proposed models, our results about the main covariate hs
(implanted aortic prosthesis type of valve: stentless porcine tissue or homograft tissue) are different from
the results of studies (Siniawski et al. 2003 and Marathe et al. 2019). According to Siniawski et al. (2003),
the stentless valves perform better to increase the life expectancy after surgery than homograft valves based
on sixty day mortality rate and Marathe et al. (2019) also suggested that stentless valve is a better choice
than homograft valve to increase the survival rate. But the results from our study showed that there is no
significant effect with respect to valve type implanted during surgery on the risk of death (Table 4.2: 95 %
credible interval include zero), i.e., there is no significant difference between the efficiency of two types of
valves implanted during surgery based on tissue type (Stentless porcine tissue or Homograft) associated with
reducing the risk of death in the patients after surgery. One possible reason for this nonsignificant result is
that only 21 % patients experienced the event (death) until the end of the study (Table 4.1).
Moreover, the association between the two processes, longitudinal and time to event outcome was assessed
and found statistically significant strong association between longitudinal response log.lvmi measurement and
risk of death. From the results we concluded, one gm/m2 increase in the value of log.lvmi after the surgery
reduces the relative risk of death by about 62 % (model 1,Table 4.2) and 60 % (model 2, Table 4.2), respec-
tively, after controlling for other factors. Our result is similar to the result of a study conducted by Lindman
et al. (2014). According to Lindman et al. (2014), a better quality of life trend was noticed in patients with
greater LVMI regression after the AVR surgery. Since our results indicate that there is a strong significant
association between internal time-dependent covariate (longitudinal outcome) log.lvmi and the risk of death
after the aortic heart valve replacement surgery. Therefore, ignoring this association may lead to biased
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estimates (Guo and Carlin 2004) and cannot reveal the potential association among the responses of both
processes, which could be of paramount importance. Thus, a joint analysis should be considered to better
understand the joint longitudinal and time to event processes rather than separate analysis of both processes
for aortic valve replacement data.
Furthermore, Based on DIC values for the model selection between both Log-logistic and Weibull dis-
tribution, Bayesian joint AFT model with Weibull distribution fits the motivated data set more efficiently
in the sense of goodness of fit and the principle of parsimonious as compare to the Bayesian joint AFT
model with Log-Logistic distribution. Therefore, we recommend, Bayesian joint models with AFT Weibull
distribution to jointly analyze the longitudinal and survival data of the aortic valve replacement surgery to
predict and control the future performance of heart function lvmi of the aortic valve and the survival of the
patients.
We hoped that these findings would contribute to help surgeons and cardiologists to refine the indica-
tions, timing, prognostication, and follow-up of patients before and after aortic valve replacement surgery and
these findings would contribute to developing the targeted policies and programs regarding the prevention
after AVR to increase the life expectancy of patients even in elders. Moreover, these findings will be benefi-
cial to reduce the burden of cost on healthcare and the individuals who are suffering from heart valve diseases.
5.1 Limitation of Study
There are some limitations of this study that should be considered while performing the analysis.
1. The choice of poor selection of initial values may result in slow-mixing for a Markov chain. Hence, the
selection of initial values should be chosen carefully to avoid lengthy runs.
2. The choice of prior distribution should be made carefully because Bayesian methods are sensitive to
the choice of prior distributions. In the absence of the prior information, non-informative priors or flat
priors may be the better choice.
3. Monte Carlo methods can be computationally expensive if the dimensions of the random effects bi are
very large.
5.2 Future Work
In this section, we discuss some possible future extensions of our work.
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1. Addressing the association via random intercepts or random slopes for AFT models could be an area
of future research.
2. In this thesis, we focused on the development of the joint model, and we did not discuss anything
about the diagnostics of the longitudinal and survival sub-models to check the adequacy of the models
in the joint modeling framework with AFT models. Hence on possible future work is to consider the
diagnostic of the longitudinal and survival sub-models using residual plots.
3. In this study, we applied the joint modeling approach for one continuous longitudinal outcome and one
event of occurrence. The future extensions of the shared parameter joint model will be considered with
multivariate biomarkers outcome for longitudinal process and competing risks for survival process.
4. In recent work, we only consider the data under the right censoring. We have the plan to work with a
data set involving both left-truncation and right censoring in the joint modeling framework with AFT
models in the future.
5. For the model selection, we only use the Deviance Information Criterion (DIC). Considering the other
model selection criterion, including Akaike’s information criterion (AIC), Bayesian information criterion
(BIC), and Watanabe-Akaike information criterion (WAIC) along with DIC is also a future research
topic of interest.
6. In this thesis we did not discuss anything about the comparison of proposed models with other models,
therefore conducting the simulation study for our proposed Joint Bayesian models with suggested
parametric AFt model could be one of the possible future work.
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Appendix A
Parametric Distributions: Table 2.1
A.1 Exponential Distributions
The exponential distribution is the simplest model, and It has only one parameter ρ. ρ is the rate parameters
and the scale parameters can be obtained by, λ = ρ−1. Since this distribution has no information about the
shape, therefore not flexible enough to describe hazard shapes for time-to-event data. However, the large
value of ρ indicates short survival and high risk, where the small value of ρ indicates long survival and low
risk.
A.2 Weibull Distribution
The Weibull distribution (Weibull and Stockholm 1951) is a generalization of the exponential distribution.
Weibull distribution has two parameters, shape (κ > 0) and rate (ρ > 0) parameters. In survival analysis,
Weibull distribution is the most widely used distribution.Weibull distribution can model different types of
data (either skewed or symmetric distributional shape). It is particularly popular in engineering applications.
The model from Weibull distribution is flexible and accommodates monotone hazard shapes. In this thesis,
we use Weibull distribution to compare our proposed log-logistic distribution, both distribution under the
AFT model setting.
A.3 Log-Logistic Distribution
The log-logistic distribution is particularly useful to model unimodal (i.e., non-monotone) hazard functions.
This distribution has two parameters, rateρ > 0 and κ > 0. ρ is the rate parameter and κ is the shape
parameter. The hazard function of the log-logistic distribution is monotone decreasing for κ ≤ 1 and
unimodal (non-monotone) for κ > 1.
The log-logistic distribution widely used when the mortality increase and reaches a peak after some finite
time point and then slowly decrease (Bennett 1983). For example, the log-logistic model can be used to
describe the lifetimes of breast cancer patients (peak mortality of breast cancer patients occurs after about
three years (Langlands et al. 1979)). In this thesis, our focus is on log-logistic distribution under the AFT
model setting.
A.4 Logistic Distribution
Logistic distribution; −∞ < µ <∞ is the location parameter and σ > 0 is the scale parameter of distribution.
Note that: log-logistic is a survival distribution, but logistic is not.
A.5 Log-normal Distribution
Another popular model to model the unimodal (i.e., non-monotone) hazard function is, log-normal distribu-
tion. Φ(.) for the distribution is the cumulative distribution function of standard normal distribution and
parameters of distribution are defined as; −∞ < µ <∞ and σ > 0.
Log-Logistic and log-normal distributions have the same shape for the hazard functions.
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A.6 Gamma Distribution
The gamma distribution is not widely used in survival statistical as the Weibull, log-logistic and log-normal
distributions because, from a computational point of view, the survivor and the hazard functions of the
gamma distribution are intractable. Despite the limitation of gamma distribution it has been used to model
lifetimes of technical systems with repeated repairing after failure, rainfall data in meteorology, and insurance
claims and loan data in business (Thom 1958).
For gamma distribution the rate parameter is ρ−1 > 0 and shape parameter is κ > 0. For gamma distribution
the hazard function is monotone increasing function if κ > 1 and monotone decreasing for 0 < κ < 1.
A.7 Gompertz Distribution
Benjamin Gompertz, a British actuary, introduced a law of mortality, which is nowadays called the Gompertz
law of mortality (Conn 2006). He assumed the exponential increase of mortality with age. In the distribution,
t is the follow-up time and a > 0 are the distribution parameters.
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Appendix B
Gauss-Legendre Quadrature Rule for Numerical In-
tegration
In numerical analysis, a quadrature rule is used for an approximation of the definite integral of a function,
This approximation is usually known as a weighted sum of function values at some specified points within
the domain of integration.
An n-point Gaussian quadrature rule, named after German mathematician and physicist Carl Friedrich
Gauss, is a quadrature rule constructed to yield an exact result for polynomials of degree (2n− 1) or less by
a suitable choice of the nodes xj and weights wj for j = 1, ..., n. The domain of integral for such a rule is






which is exact for polynomials of degree 2n-1 or less. This exact rule is known as the Gauss-Legendre
quadrature rule. The quadrature rule will only be an accurate approximation to the integral above if f(x)
is well-approximated by a polynomial of degree 2n-1 or less on [- 1,1]. The quadrature nodes are defined as







Where Pn represents the Legendre polynomials.
Moreover, if the domain of integration is different from [-1, 1], first we mustl transform the domain and
then apply the rule to approximate the integration value. For example if the domain of integral is [a, b] then















The nodes and weights for 5-point Gauss-Legendre quadrature rule are given in the following Table B.1
(for more details see Press et al. 2007).
Table B.1: Nodes and Weights of 5-point Gauss-Legendre quadrature
Nodes xi 0.9061798459 -0.9061798459 0.5384693101 -0.5384693101 0.00
Weights wi 0.2369268851 0.2369268851 0.4786286705 0.4786286705 0.5688888888
To evaluate the integral in equation (4.14), we use 5-point Gauss-Legendre rule. First we change the
domain of integral [0, t] so that its range is from [-1, 1]. for this purpose we substitute a = 0 and b = ti and
























In our implementation, first we compute ti2 xj +
ti
2 for each individual i. Then we integrate our function
gi(ti) at these values in WinBUGS.
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Appendix C
Gelman-Rubin Statistics R: For Bayesian Joint AFT
Log-logistic and Weibull Distribution
Gelman-Rubin Statistics for Bayesian Joint AFT Log-logistic and Weibull Distribution is given below
Table C.1: Gelman-Rubin statistics results
Log-Logistic Weibull
Parameters Test statistics value Test statistics value
α1 (Intercept) 1.00 1.00
α2 (time) 1.00 1.00
α3 (hs) 1.00 1.00
α4 (lv1) 1.00 1.00
α5 (lv2) 1.00 1.00
α6 (redo) 1.00 1.00
α7 (dm) 1.00 1.00
α8 (age) 1.00 1.00
α9 (sex) 1.00 1.00
β1 (hs) 1.00 1.00
β2 (lv1) 1.00 1.00
β3 (lv2) 1.00 1.00
β4 (redo) 1.00 1.00
β5 (dm) 1.00 1.00
β6 (age) 1.03 1.02
β7 (sex) 1.00 1.00
φ(Association) 1.00 1.00
κ(shape) 1.01 1.00
ρ (rate) 1.01 1.03
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Appendix D
WinBUGS Codes to Fit Proposed Joint Models





for (i in 1:n) {
for (j in n1[i]: n2[i]) {
y[j] ∼ dnorm(muy[j], inv.sigSqu)
muy[j] <- inprod2(alpha[1:p1], xlong[j,1: p1]) + inprod2(u[i,1:pp1], zlong[j,1:pp1])
}
zeros[i] ∼ dpois(zeros.mean[i])
zeros.mean[i] <- -l[i] + const
pred0[i] <- inprod2(beta[1:p2], xsurv[i,1: p2])
pred1[i] <- pred0[i] + phi*inprod2(u[i,1:pp2], zsurv[i,1: pp2])
for(k in 1: quad.points) {
psi0[i, k] <- c15[k]*exp(-phi*inprod2(u[i,1: pp2], xx15[i,1: pp2, k]))
}
psi[i] <- (sum(psi0[i,])*st[i]/2)*exp(-pred0[i])
logf[i] <- log(kappa) + kappa*log(rho) + (kappa-1)*log(psi[i]) - 2*log(1 + pow((rho*psi[i]),kappa)) - pred1[i]
logs[i] <- -log(1 + pow((rho*psi[i]), kappa))
l[i] <- status[i]*logf[i] + (1 - status[i]) logs[i]
u[i,1:pp1] ∼ dmnorm(U0[ ], inv.Sigma[,])
}
inv.Sigma[1: pp1,1: pp1] ∼ dwish(R[,], w.df)
alpha[1:p1] ∼ dmnorm(alpha.mu[ ], iSigma1[,])
beta[1:p2] ∼ dmnorm(beta.mu[ ], iSigma2[,])
phi ∼ dnorm(prior.phi.mu, prior.phi.tau)
inv.sigSqu ∼ dgamma(prior.tauz1, prior.tauz2)
kappa1∼ dgamma(prior.kappa1, prior.kappa2)
















lmeFit <- lme(log.lvmi ∼1 + time + hs + lv1 + lv2 + redo + dm + age + sex ,
random = ∼ time|num , data = heartvalve1)
summary(lmeFit)
Fixed Estimate <- fixed.effects(summary(lmeFit))
Random Estimate <- as.matrix(ranef(lmeFit))
heartvalve.id <- heartvalve1[!duplicated(heartvalve1$num), ]
################
SurvFit <- survreg(Surv(fuyrs, status)∼ hs + lv1 + lv2 + + redo + dm + age + sex ,
data = heartvalve.id, x = TRUE, dist = “loglogistic” )
summary(SurvFit)





n1 <- as.numeric(tapply(obs,num,function(x) x[1]))
n2 <- as.numeric(tapply(obs,num,function(x) x[length(x)]))
xlong0 <- data.frame(heartvalve1, int=1)
xlong <- xlong0[, c(“int”,“time”,“hs” , “lv1”, “lv2”, “redo”, “dm” , “age”, “sex”)]
p1 <- ncol(xlong)
zlong <- xlong0[, c(“int”,“time”) ]
pp1 <- ncol (zlong)
SurvCov <- UniqueVariables(xlong0,c(“int”,“hs” , “lv1”, “lv2”, “redo”, “dm” ,
“age”, “sex”, “fuyrs”,“status”), id.col=“num”)
xsurv <- SurvCov[, c(“hs” , “lv1”, “lv2”, “redo”, “dm” , “age”, “sex”)]
zsurv <- SurvCov [, c(“int”, “fuyrs”)]
st <- SurvCov [, “fuyrs”]
status <- SurvCov [, “status”]
p2 <- ncol(xsurv)
pp2 <- ncol(zsurv)
######## 5 Points Gauss-Legender quadrature rule ########
######## Weights ########
c15 <- c(0.2369268850561891,0.2369268850561891, 0.4786286704993665,
0.4786286704993665, 0.5688888888888889)
######## Nodes ########
t15 <- c(0.9061798459386640, -0.9061798459386640, 0.5384693101056831,
-0.5384693101056831, 0.0000000000000000)
quad.points <- length(t15)
x150 <- sapply (st,function(st){0.5*(st*t15 + st)})
x15 <- t(x150)
zsurv2 <- cbind(zsurv[,“int”], x15)
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xx150 <- cbind (zsurv2[, c (1,2)], zsurv2[, c (1,3)], zsurv2[, c (1,4)], zsurv2[, c (1,5)], zsurv2[, c (1,6)])
xx15 <- array (xx150, dim=c(n, pp2, quad.points))
######## Initialize longitudinal parameters ########
u init <- Random Estimate
alpha init <- Fixed Estimate
######## Initialize survival parameters ########
beta init = SurvFit$coeff[-1]
init kappa <- 1/(SurvFit$scale)
init rho <- exp(-SurvFit$coeff[1])
init phi <- 0
inv.Sigma.u init <- diag(0.1,pp1)
data <- list(n=n,n1=n1,n2=n2,p1=p1,p2=p2,pp1=pp1,pp2=pp2,y=y, xlong=as.matrix(xlong),
zlong=as.matrix(zlong), st=st,status=status,xsurv=as.matrix(xsurv), zsurv=as.matrix(zsurv),
zeros=rep(0,n), const=0,R=diag(0.01, pp1),iSigma1=diag(0.00001, p1), iSigma2=diag(0.00001, p2),
alpha.mu=rep(0,p1), beta.mu=rep(0, p2),U0=rep(0,pp1),w.df=pp1+1, prior.phi.mu=0,
prior.phi.tau=0.0001, prior.tauz1=0.1,prior.tauz2=0.1, prior.kappa1=0.1,prior.kappa2=0.1,
prior.rho1=0.1,prior.rho2=0.1, xx15=xx15,c15=c15,quad.points=5)
parameters.bugs <- c(“alpha”, “beta”, “phi”, “kappa”, “rho”, “logkappa”, “logrho”, “inv.sigSqu”,
“inv.Sigma”, “deviance”, “logs”, “u”)
inits.bugs <- rep(list(list(alpha=alpha init,beta=beta init,phi=init phi,inv.sigSqu=1,
inv.Sigma=inv.Sigma.u init,kappa1=1/init kappa,rho=init rho,u=u init)),2)
heartvalve1.sim <- bugs(data=data, inits=inits.bugs, parameters.to.save=parameters.bugs,bugs.model,

















for (i in 1:n) {
for (j in n1[i]: n2[i]) {
y[j] ∼ dnorm(muy[j], inv.sigSqu)
muy[j] <- inprod2(alpha[1:p1], xlong[j,1: p1]) + inprod2(u[i,1: pp1], zlong[j,1: pp1])
}
zeros[i] ∼ dpois(zeros.mean[i])
zeros.mean[i] <- - l[i] + const
pred0[i] <- inprod2(beta[1: p2], xsurv[i,1: p2])
pred1[i] <- pred0[i] + phi*inprod2(u[i,1: pp2], zsurv[i,1: pp2])
for(k in 1:quad.points){
psi0[i,k] <- c15[k]*exp(- phi*inprod2(u[i,1:pp2], xx15[i,1:pp2,k]))
}
psi[i] <- (sum(psi0[i,])*st[i]/2)*exp(-pred0[i])
logf[i] <- log(kappa) + kappa*log(rho) + (kappa-1)*log(psi[i]) - pow((rho*psi[i]),kappa) - pred1[i]
logs[i] <- - pow((rho*psi[i]), kappa)
l[i] <- status[i]*logf[i]+(1 - status[i])*logs[i]
u[i,1:pp1] ∼ dmnorm(U0[], inv.Sigma[,])
}
inv.Sigma[1: pp1,1: pp1] ∼ dwish(R[,], w.df)
alpha[1: p1] ∼ dmnorm(alpha.mu[], iSigma1[,])
beta[1:p2] ∼ dmnorm(beta.mu[], iSigma2[,])
phi ∼ dnorm(prior.phi.mu, prior.phi.tau)
inv.sigSqu ∼ dgamma(prior.tauz1, prior.tauz2)
kappa1 ∼ dgamma(prior.kappa1, prior.kappa2)












heartvalve1 <- cbind (heart.valve, lv1,lv2)
heartvalve1$hs <- ifelse(as.numeric(heartvalve1$hs)==2,0,1)
################
lmeFit <- lme(log.lvmi ∼1 + time + hs + lv1 + lv2 + redo + dm + age + sex ,
random = ∼ time|num , data = heartvalve1)
summary(lmeFit)
Fixed Estimate <- fixed.effects(summary(lmeFit))
Random Estimate <- as.matrix(ranef(lmeFit))
heartvalve.id <- heartvalve1[!duplicated(heartvalve1$num), ]
################
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SurvFit <- survreg(Surv(fuyrs, status) ∼ hs + lv1 + lv2 + + redo + dm + age + sex ,
data = heartvalve.id, x = TRUE, dist = “weibull”)
summary(SurvFit)





n1 <- as.numeric(tapply(obs,num,function(x) x[1]))
n2 <- as.numeric(tapply(obs,num,function(x) x[length(x)]))
xlong0 <- data.frame(heartvalve1, int=1)
xlong <- xlong0[, c(“int”,“time”,“hs” , “lv1”, “lv2”, “redo”, “dm” , “age”, “sex”)]
p1 <- ncol(xlong)
zlong <- xlong0[, c(“int”,“time”) ]
pp1 <- ncol (zlong)
SurvCov <- UniqueVariables(xlong0,c(“int”,“hs” , “lv1”, “lv2”, “redo”, “dm” ,
“age”, “sex”, “fuyrs”,“status”), id.col=“num”)
xsurv <- SurvCov[, c(“hs” , “lv1”, “lv2”, “redo”, “dm” , “age”, “sex”)]
zsurv <- SurvCov [, c(“int”, “fuyrs”)]
st <- SurvCov [, “fuyrs”]
status <- SurvCov [, “status”]
p2 <- ncol(xsurv)
pp2 <- ncol(zsurv)
######## 5 Points Gauss-Legender quadrature rule ########
######## Weights ########
c15 <- c(0.2369268850561891,0.2369268850561891, 0.4786286704993665,
0.4786286704993665, 0.5688888888888889)
######## Nodes ########
t15 <- c(0.9061798459386640, -0.9061798459386640, 0.5384693101056831,
-0.5384693101056831, 0.0000000000000000)
quad.points <- length(t15)
x150 <- sapply (st,function(st){0.5*(st*t15 + st)})
x15 <- t(x150)
zsurv2 <- cbind(zsurv[,“int”], x15)
xx150 <- cbind (zsurv2[, c (1,2)], zsurv2[, c (1,3)], zsurv2[, c (1,4)], zsurv2[, c (1,5)], zsurv2[, c (1,6)])
xx15 <- array (xx150, dim=c(n, pp2, quad.points))
######## Initialize longitudinal parameters ########
u init <- Random Estimate
alpha init <- Fixed Estimate
######## Initialize survival parameters ########
beta init = SurvFit$coeff[-1]
init kappa <- 1/(SurvFit$scale)
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init rho <- exp(-SurvFit$coeff[1])
init phi <- 0
inv.Sigma.u init <- diag(0.1,pp1)
data <- list(n=n,n1=n1,n2=n2,p1=p1,p2=p2,pp1=pp1,pp2=pp2,y=y, xlong=as.matrix(xlong),
zlong=as.matrix(zlong), st=st,status=status,xsurv=as.matrix(xsurv), zsurv=as.matrix(zsurv),
zeros=rep(0,n), const=0,R=diag(0.01, pp1),iSigma1=diag(0.00001, p1), iSigma2=diag(0.00001, p2),
alpha.mu=rep(0,p1), beta.mu=rep(0, p2),U0=rep(0,pp1),w.df=pp1+1, prior.phi.mu=0,
prior.phi.tau=0.0001, prior.tauz1=0.1,prior.tauz2=0.1, prior.kappa1=0.1,prior.kappa2=0.1,
prior.rho1=0.1,prior.rho2=0.1, xx15=xx15,c15=c15,quad.points=5)
parameters.bugs <- c(“alpha”, “beta”, “phi”, “kappa”, “rho”, “logkappa”, “logrho”, “inv.sigSqu”,
“inv.Sigma”, “deviance”, “logs”, “u”)
inits.bugs <- rep(list(list(alpha=alpha init,beta=beta init,phi=init phi,inv.sigSqu=1,
inv.Sigma=inv.Sigma.u init,kappa1=1/init kappa,rho=init rho,u=u init)),2)
heartvalve1.sim <- bugs(data=data, inits=inits.bugs, parameters.to.save=parameters.bugs,bugs.model,
n.chains=2, n.iter=150000, n.burnin=15000, n.thin=5, DIC=TRUE, program=“WinBUGS”,
bugs.directory=“C:/winBUGS14”)
summary(heartvalve1.sim)
chain1 <- heartvalve1.sim$sims.array[,1,]
chain2 <- heartvalve1.sim$sims.array[,2,]
mcmc.sim <- mcmc.list(mcmc(chain1),mcmc(chain2))
summary(mcmc.sim)
gelman.diag(mcmc.sim, autoburnin=TRUE, multivariate=FALSE)
plot(mcmc.sim,density=F,trace=T, ask=TRUE)
plot(mcmc.sim,density=T,trace=F, ask=TRUE)
Print(heartvalve1.sim)
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